Transcriptional	O
activation	O
of	O
human	B-DNA
zeta	I-DNA
2	I-DNA
globin	I-DNA
promoter	I-DNA
by	O
the	O
alpha	B-DNA
globin	I-DNA
regulatory	I-DNA
element	I-DNA
(	O
HS-40	B-DNA
)	O
:	O
functional	O
role	O
of	O
specific	O
nuclear	B-protein
factor-DNA	I-protein
complexes	I-protein
.	O

We	O
studied	O
the	O
functional	O
interaction	O
between	O
human	B-DNA
embryonic	I-DNA
zeta	I-DNA
2	I-DNA
globin	I-DNA
promoter	I-DNA
and	O
the	O
alpha	B-DNA
globin	I-DNA
regulatory	I-DNA
element	I-DNA
(	O
HS-40	B-DNA
)	O
located	O
40	B-DNA
kb	I-DNA
upstream	I-DNA
of	O
the	O
zeta	B-DNA
2	I-DNA
globin	I-DNA
gene	I-DNA
.	O

It	O
was	O
shown	O
by	O
transient	O
expression	O
assay	O
that	O
HS-40	B-DNA
behaved	O
as	O
an	O
authentic	O
enhancer	B-DNA
for	O
high-level	O
zeta	B-DNA
2	I-DNA
globin	I-DNA
promoter	I-DNA
activity	O
in	O
K562	B-cell_line
cells	I-cell_line
,	O
an	O
erythroid	O
cell	O
line	O
of	O
embryonic	O
and/or	O
fetal	O
origin	O
.	O

Although	O
sequences	O
located	O
between	O
-559	O
and	O
-88	O
of	O
the	O
zeta	B-DNA
2	I-DNA
globin	I-DNA
gene	I-DNA
were	O
dispensable	O
for	O
its	O
expression	O
on	O
enhancerless	B-DNA
plasmids	I-DNA
,	O
they	O
were	O
required	O
for	O
the	O
HS-40	B-DNA
enhancer	I-DNA
-mediated	O
activity	O
of	O
the	O
zeta	B-DNA
2	I-DNA
globin	I-DNA
promoter	I-DNA
.	O

Site-directed	O
mutagenesis	O
demonstrated	O
that	O
this	O
HS-40	B-DNA
enhancer-	O
zeta	B-DNA
2	I-DNA
globin	I-DNA
promoter	I-DNA
interaction	O
is	O
mediated	O
by	O
the	O
two	O
GATA-1	O
factor	O
binding	O
motifs	O
located	O
at	O
-230	O
and	O
-104	O
,	O
respectively	O
.	O

The	O
functional	O
domains	O
of	O
HS-40	B-DNA
were	O
also	O
mapped	O
.	O

Bal	O
31	O
deletion	O
mapping	O
data	O
suggested	O
that	O
one	O
GATA-1	O
motif	O
,	O
one	O
GT	O
motif	O
,	O
and	O
two	O
NF-E2/AP1	O
motifs	O
together	O
formed	O
the	O
functional	O
core	O
of	O
HS-40	B-DNA
in	O
the	O
erythroid-specific	O
activation	O
of	O
the	O
zeta	B-DNA
2	I-DNA
globin	I-DNA
promoter	I-DNA
.	O

Site-directed	O
mutagenesis	O
further	O
demonstrated	O
that	O
the	O
enhancer	B-DNA
function	O
of	O
one	O
of	O
the	O
two	O
NF-E2/AP1	O
motifs	O
of	O
HS-40	B-DNA
is	O
mediated	O
through	O
its	O
binding	O
to	O
NF-E2	B-protein
but	O
not	O
AP1	B-protein
transcription	I-protein
factor	I-protein
.	O

Finally	O
,	O
we	O
did	O
genomic	O
footprinting	O
of	O
the	O
HS-40	B-DNA
enhancer	I-DNA
region	I-DNA
in	O
K562	B-cell_line
cells	I-cell_line
,	O
adult	B-cell_line
nucleated	I-cell_line
erythroblasts	I-cell_line
,	O
and	O
different	O
nonerythroid	B-cell_type
cells	I-cell_type
.	O

All	O
sequence	O
motifs	O
within	O
the	O
functional	O
core	O
of	O
HS-40	B-DNA
,	O
as	O
mapped	O
by	O
transient	O
expression	O
analysis	O
,	O
appeared	O
to	O
bind	O
a	O
nuclear	B-protein
factor	I-protein
(	O
s	O
)	O
in	O
living	O
K562	B-cell_line
cells	I-cell_line
but	O
not	O
in	O
nonerythroid	B-cell_type
cells	I-cell_type
.	O

On	O
the	O
other	O
hand	O
,	O
only	O
one	O
of	O
the	O
apparently	O
nonfunctional	B-DNA
sequence	I-DNA
motifs	I-DNA
was	O
bound	O
with	O
factors	O
in	O
vivo	O
.	O

In	O
comparison	O
to	O
K562	B-cell_line
,	O
nucleated	B-cell_line
erythroblasts	I-cell_line
from	O
adult	O
human	O
bone	O
marrow	O
exhibited	O
a	O
similar	O
but	O
nonidentical	O
pattern	O
of	O
nuclear	B-protein
factor	I-protein
binding	O
in	O
vivo	O
at	O
the	O
HS-40	B-DNA
region	O
.	O

These	O
data	O
suggest	O
that	O
transcriptional	O
activation	O
of	O
human	B-DNA
embryonic	I-DNA
zeta	I-DNA
2	I-DNA
globin	I-DNA
gene	I-DNA
and	O
the	O
fetal/adult	B-DNA
alpha	I-DNA
globin	I-DNA
genes	I-DNA
is	O
mediated	O
by	O
erythroid	O
cell-specific	O
and	O
developmental	B-protein
stage-specific	I-protein
nuclear	I-protein
factor-DNA	I-protein
complexes	I-protein
which	O
form	O
at	O
the	O
enhancer	B-DNA
(	O
HS-40	B-DNA
)	O
and	O
the	O
globin	B-DNA
promoters	I-DNA
.	O

MoLECcULAR	NULL
AND	NULL
CELLULAR	NULL
BroLrooy	NULL
,	NULL
Apr	NULL
.	NULL

1993	NULL
,	NULL
p.	NULL
2298-2308	NULL
0270-7306/93/042298-11	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

4	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Human	NULL
{	NULL
2	NULL
Globin	NULL
Promoter	NULL
by	NULL
the	NULL
a	NULL
Globin	NULL
Regulatory	NULL
Element	NULL
(	NULL
HS-40	NULL
)	NULL
:	NULL
Functional	NULL
Role	NULL
of	NULL
Specific	NULL
Nuclear	NULL
Factor-DNA	NULL
Complexes	NULL
QINGYI	NULL
ZHANG	NULL
,	NULL
``	NULL
P.	NULL
M.	NULL
SEKHAR	NULL
REDDY	NULL
,	NULL
``	NULL
CHUN-YUAN	NULL
YU	NULL
,	NULL
``	NULL
CAROL	NULL
BASTIANI	NULL
,	NULL
'	NULL
DOUG	NULL
HIGGS,2	NULL
GEORGE	NULL
STAMATOYANNOPOULOS	NULL
,	NULL
*	NULL
THALIA	NULL
PAPAYANNOPOULOU	NULL
,	NULL
®	NULL
anp	NULL
C.-K.	NULL
JAMES	NULL
SHEN'*	NULL
Department	NULL
of	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Davis	NULL
,	NULL
California	NULL
95616	NULL
;	NULL
MRC	NULL
Molecular	NULL
Haematology	NULL
Unit	NULL
,	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
John	NULL
Radcliffe	NULL
Hospital	NULL
,	NULL
Headington	NULL
,	NULL
Oxford	NULL
,	NULL
United	NULL
Kingdom	NULL
``	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Medical	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98195	NULL
Received	NULL
4	NULL
September	NULL
1992/Returned	NULL
for	NULL
modification	NULL
30	NULL
November	NULL
1992/Accepted	NULL
12	NULL
January	NULL
1993	NULL
We	NULL
studied	NULL
the	NULL
functional	NULL
interaction	NULL
between	NULL
human	NULL
embryonic	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
and	NULL
the	NULL
«	NULL
globin	NULL
regulatory	NULL
element	NULL
(	NULL
HS-40	NULL
)	NULL
located	NULL
40	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
by	NULL
transient	NULL
expression	NULL
assay	NULL
that	NULL
HS-40	NULL
behaved	NULL
as	NULL
an	NULL
authentic	NULL
enhancer	NULL
for	NULL
high-level	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
an	NULL
erythroid	NULL
cell	NULL
line	NULL
of	NULL
embryonic	NULL
and/or	NULL
fetal	NULL
origin	NULL
.	NULL

Although	NULL
sequences	NULL
located	NULL
between	NULL
-559	NULL
and	NULL
-88	NULL
of	NULL
the	NULL
C2	NULL
globin	NULL
gene	NULL
were	NULL
dispensable	NULL
for	NULL
its	NULL
expression	NULL
on	NULL
enhancerless	NULL
plasmids	NULL
,	NULL
they	NULL
were	NULL
required	NULL
for	NULL
the	NULL
HS-40	NULL
enhancer-mediated	NULL
activity	NULL
of	NULL
the	NULL
£2	NULL
globin	NULL
promoter	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
demonstrated	NULL
that	NULL
this	NULL
HS-40	NULL
enhancer-£2	NULL
globin	NULL
promoter	NULL
interaction	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
two	NULL
GATA-1	NULL
factor	NULL
binding	NULL
motifs	NULL
located	NULL
at	NULL
-230	NULL
and	NULL
-104	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
functional	NULL
domains	NULL
of	NULL
HS-40	NULL
were	NULL
also	NULL
mapped	NULL
.	NULL

Bai	NULL
31	NULL
deletion	NULL
mapping	NULL
data	NULL
suggested	NULL
that	NULL
one	NULL
GATA-1	NULL
motif	NULL
,	NULL
one	NULL
GT	NULL
motif	NULL
,	NULL
and	NULL
two	NULL
NF-E2/AP1	NULL
motifs	NULL
together	NULL
formed	NULL
the	NULL
functional	NULL
core	NULL
of	NULL
HS-40	NULL
in	NULL
the	NULL
erythroid-specific	NULL
activation	NULL
of	NULL
the	NULL
£2	NULL
globin	NULL
promoter	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
further	NULL
demonstrated	NULL
that	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
one	NULL
of	NULL
the	NULL
two	NULL
NF-E2/AP1	NULL
motifs	NULL
of	NULL
HS-40	NULL
is	NULL
mediated	NULL
through	NULL
its	NULL
binding	NULL
to	NULL
NF-E2	NULL
but	NULL
not	NULL
API	NULL
transcription	NULL
factor	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
did	NULL
genomic	NULL
footprinting	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
region	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
adult	NULL
nucleated	NULL
erythroblasts	NULL
,	NULL
and	NULL
different	NULL
nonerythroid	NULL
cells	NULL
.	NULL

All	NULL
sequence	NULL
motifs	NULL
within	NULL
the	NULL
functional	NULL
core	NULL
of	NULL
HS-40	NULL
,	NULL
as	NULL
mapped	NULL
by	NULL
transient	NULL
expression	NULL
analysis	NULL
,	NULL
appeared	NULL
to	NULL
bind	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
living	NULL
K562	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
nonerythroid	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
only	NULL
one	NULL
of	NULL
the	NULL
apparently	NULL
nonfunctional	NULL
sequence	NULL
motifs	NULL
was	NULL
bound	NULL
with	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
comparison	NULL
to	NULL
K562	NULL
,	NULL
nucleated	NULL
erythroblasts	NULL
from	NULL
adult	NULL
human	NULL
bone	NULL
marrow	NULL
exhibited	NULL
a	NULL
similar	NULL
but	NULL
nonidentical	NULL
pattern	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
HS-40	NULL
region	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
embryonic	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
and	NULL
the	NULL
fetal/adult	NULL
a	NULL
globin	NULL
genes	NULL
is	NULL
mediated	NULL
by	NULL
erythroid	NULL
cell-specific	NULL
and	NULL
developmental	NULL
stage-specific	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
which	NULL
form	NULL
at	NULL
the	NULL
enhancer	NULL
(	NULL
HS-40	NULL
)	NULL
and	NULL
the	NULL
globin	NULL
promoters	NULL
.	NULL

Similar	NULL
to	NULL
those	NULL
of	NULL
other	NULL
vertebrates	NULL
,	NULL
the	NULL
human	NULL
B-	NULL
and	NULL
«	NULL
-like	NULL
globin	NULL
gene	NULL
families	NULL
are	NULL
each	NULL
arranged	NULL
as	NULL
gene	NULL
clus-ters	NULL
.	NULL

The	NULL
B	NULL
cluster	NULL
is	NULL
on	NULL
chromosome	NULL
11	NULL
,	NULL
and	NULL
the	NULL
a	NULL
cluster	NULL
is	NULL
on	NULL
chromosome	NULL
16	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
5	NULL
)	NULL
.	NULL

Transcriptional	NULL
activities	NULL
of	NULL
genes	NULL
contained	NULL
within	NULL
both	NULL
clusters	NULL
are	NULL
confined	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
and	NULL
they	NULL
are	NULL
sequentially	NULL
turned	NULL
on	NULL
and	NULL
off	NULL
during	NULL
development	NULL
in	NULL
the	NULL
order	NULL
of	NULL
their	NULL
physical	NULL
arrangement	NULL
in	NULL
the	NULL
clusters	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
15	NULL
)	NULL
.	NULL

Genetic	NULL
evidence	NULL
and	NULL
direct	NULL
experimental	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
each	NULL
globin	NULL
gene	NULL
family	NULL
is	NULL
controlled	NULL
by	NULL
regulatory	NULL
elements	NULL
located	NULL
many	NULL
kilobases	NULL
upstream	NULL
of	NULL
each	NULL
gene	NULL
cluster	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
41	NULL
)	NULL
.	NULL

These	NULL
sequences	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
B	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
B-LCR	NULL
)	NULL
and	NULL
the	NULL
a	NULL
globin	NULL
regulatory	NULL
element	NULL
(	NULL
HS-40	NULL
)	NULL
,	NULL
not	NULL
only	NULL
act	NULL
as	NULL
classical	NULL
enhancers	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
(	NULL
references	NULL
21	NULL
,	NULL
22	NULL
,	NULL
28	NULL
,	NULL
35	NULL
,	NULL
and	NULL
42	NULL
and	NULL
this	NULL
study	NULL
)	NULL
but	NULL
also	NULL
confer	NULL
erythroid	NULL
lincage-specific	NULL
and	NULL
integration	NULL
site-independent	NULL
expression	NULL
of	NULL
linked	NULL
promoters	NULL
in	NULL
stably	NULL
transformed	NULL
cell	NULL
lines	NULL
or	NULL
transgenic	NULL
mice	NULL
(	NULL
11	NULL
,	NULL
12	NULL
;	NULL
reviewed	NULL
in	NULL
references	NULL
7	NULL
,	NULL
25	NULL
,	NULL
and	NULL
36	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
B-LCR	NULL
(	NULL
8	NULL
,	NULL
11	NULL
,	NULL
41	NULL
)	NULL
,	NULL
the	NULL
location	NULL
of	NULL
«	NULL
globin	NULL
regulatory	NULL
element	NULL
was	NULL
first	NULL
mapped	NULL
near	NULL
one	NULL
of	NULL
four	NULL
erythroid	NULL
cell-specific	NULL
,	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
located	NULL
10	NULL
to	NULL
40	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
embryonic	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
(	NULL
12	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Further	NULL
fine-mapping	NULL
studies	NULL
have	NULL
located	NULL
the	NULL
a	NULL
globin	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

2298	NULL
regulatory	NULL
elements	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
HS-40	NULL
,	NULL
within	NULL
a	NULL
350-bp	NULL
Taql-XmnI	NULL
fragment	NULL
located	NULL
40	NULL
kb	NULL
away	NULL
from	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
(	NULL
14	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
in	NULL
cis	NULL
of	NULL
HS-40	NULL
confers	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
«	NULL
globin	NULL
gene	NULL
in	NULL
stably	NULL
transformed	NULL
cell	NULL
cultures	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
transgenic	NULL
mice	NULL
in	NULL
a	NULL
developmental	NULL
stage-specific	NULL
manner	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
B-LCR	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
HS-40	NULL
activates	NULL
transcription	NULL
of	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
genes	NULL
in	NULL
erythroid	NULL
cells	NULL
are	NULL
unknown	NULL
.	NULL

However	NULL
,	NULL
data	NULL
from	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
B	NULL
globin	NULL
locus	NULL
(	NULL
references	NULL
2	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
18	NULL
,	NULL
22	NULL
,	NULL
24	NULL
,	NULL
27	NULL
,	NULL
35	NULL
,	NULL
and	NULL
39	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
and	NULL
genomic	NULL
footprinting	NULL
of	NULL
the	NULL
B-LCR	NULL
of	NULL
both	NULL
humans	NULL
(	NULL
13	NULL
,	NULL
30	NULL
,	NULL
38	NULL
)	NULL
and	NULL
mice	NULL
(	NULL
31	NULL
)	NULL
suggest	NULL
that	NULL
these	NULL
enhancer-promoter	NULL
interactions	NULL
are	NULL
mediated	NULL
by	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
formed	NULL
at	NULL
the	NULL
enhancers	NULL
and	NULL
individual	NULL
globin	NULL
upstream	NULL
promoters	NULL
.	NULL

Because	NULL
HS-40	NULL
was	NULL
identified	NULL
more	NULL
recently	NULL
,	NULL
relatively	NULL
less	NULL
is	NULL
known	NULL
about	NULL
this	NULL
enhancer	NULL
region	NULL
than	NULL
the	NULL
B-LCR	NULL
.	NULL

First	NULL
,	NULL
although	NULL
HS-40	NULL
activates	NULL
transcription	NULL
of	NULL
the	NULL
a	NULL
globin	NULL
genes	NULL
(	NULL
12	NULL
,	NULL
14	NULL
,	NULL
28	NULL
)	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
it	NULL
is	NULL
also	NULL
an	NULL
erythroid-specific	NULL
enhancer	NULL
for	NULL
embryonic	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
expression	NULL
.	NULL

Second	NULL
,	NULL
if	NULL
HS-40	NULL
indeed	NULL
activates	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
,	NULL
where	NULL
are	NULL
the	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
functional	NULL
interaction	NULL
in	NULL
vivo	NULL
between	NULL
these	NULL
two	NULL
regulatory	NULL
elements	NULL
?	NULL

This	NULL
question	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
since	NULL
both	NULL
regulatory	NULL
elements	NULL
bind	NULL
multiple	NULL
nuclear	NULL
factors	NULL
in	NULL
vitro	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
14	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
comparative	NULL
analysis	NULL
of	NULL
the	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
(	NULL
A	NULL
)	NULL
LCR	NULL
wo	NULL
?	NULL

tv	NULL
TEromErE	NULL
Y	NULL
oy	NULL
HS-40	NULL
GATA	NULL
(	NULL
a	NULL
)	NULL
5	NULL
GT4	NULL
GATA-1	NULL
SNF-E2	NULL
3NF-E2	NULL
(	NULL
b	NULL
)	NULL
__	NULL
/AP1	NULL
Taql	NULL
(	NULL
B	NULL
)	NULL
+1	NULL
GATA-1a	NULL
TCGACCCTCTGGAAQCTATC	NULL
AGGGACCACAGTCAGCCAGG	NULL
AGGTGGGAGACCTTGGATAG	NULL
__TCCCTGGTGTCAGTCGGTCC	NULL
GATA-1b	NULL
GTGGGGGTCTGTGAAAACAC	NULL
TTGAGGGAG	NULL
TGG	NULL
CACCCCCAGACACTTTTGTG	NULL
AACTCCCTCG	NULL
Ace	NULL
3	NULL
!	NULL

NE-E2/AP1	NULL
T-II	NULL
_	NULL
GT-III	NULL
CTGAGTC	NULL
CCTGTGG	NULL
AGGTGGGACAAGGGAAAG	NULL
GACTCAGTRGGACACCqCCA	NULL
__CqTccaccecTerTccctTTe	NULL
GATA-1d	NULL
CCCCCTCCTGITTATCTIGAG	NULL
AGGGAAGGCCATGCCCAAAG	NULL
GGGGGAGGACMAATAGACTC	NULL
TCCCTTCCGGTACGGGTTTC	NULL
AGTAAATACGTTCTTCATCT	NULL
GGAGCTGAAGAAATTC-3	NULL
'	NULL
TCATTTATGCAAGAAGTAGA	NULL
CCTCGACTTCTTTAAG-5	NULL
'	NULL
ENHANCER-PROMOTER	NULL
INTERACTION	NULL
OF	NULL
HUMAN	NULL
{	NULL
2	NULL
GLOBIN	NULL
GENE	NULL
{	NULL
2	NULL
wel	NULL
wal	NULL
/AP1	NULL
I	NULL
Ig	NULL
-	NULL
IV	NULL
A_	NULL
C7	NULL
_	NULL
Gm	NULL
``	NULL
_~	NULL
0	NULL
GT-IVv	NULL
2299	NULL
10	NULL
kb	NULL
--	NULL
A	NULL
«	NULL
2	NULL
O1	NULL
C1	NULL
__	NULL
ceENTROMERE	NULL
CHROMOSOME	NULL
16	NULL
30	NULL
bp	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
q	NULL
GT	NULL
XmaI	NULL
GT-I	NULL
+80	NULL
AAGGGTGGAGGCATGCAGCT	NULL
TTCCCACCTCCGTACGTCGA	NULL
+160	NULL
TCTGGAGGCCAACAGGAC	NULL
AGACCTCCGGTTGTCCTG	NULL
CAAGCACATCTGCCCAAGCC	NULL
GTTCGTGTAGACGGGTTCGG	NULL
5'NF-E2/AP1	NULL
GCCAACCMTGACTCAGTGCT	NULL
CGGTTGGTACTGAGTCACGA	NULL
GATA-1¢	NULL
+240	NULL
GGGTGAATGGTACTGGTGAT	NULL
-	NULL
TACAACCTCTGGTGCTGCCT	NULL
CCCACTTACCATGACGACTA	NULL
_	NULL
ATGTTGGAGACCACGACGGA	NULL
+320	NULL
TGTTCACAGCCAGGCTTCAG	NULL
GGGCAAAGCCTGACCUCAGAC	NULL
ACAAGTGTCGGTCCGAAGTC	NULL
CCCGTTTCGGACTGGGTCTG	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Linkage	NULL
map	NULL
of	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
gene	NULL
cluster	NULL
.	NULL

The	NULL
directions	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
{	NULL
2	NULL
,	NULL
«	NULL
2	NULL
,	NULL
«	NULL
1	NULL
,	NULL
and	NULL
01	NULL
genes	NULL
are	NULL
from	NULL
left	NULL
to	NULL
right	NULL
.	NULL

Vertical	NULL
arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
four	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
(	NULL
HS	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
nuclear	NULL
factor	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
350-bp	NULL
Taql-XmnI	NULL
fragment	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
a	NULL
globin	NULL
regulatory	NULL
element	NULL
(	NULL
HS-40	NULL
)	NULL
,	NULL
are	NULL
indicated	NULL
by	NULL
boxes	NULL
.	NULL

The	NULL
three	NULL
GT	NULL
motif	NULL
homologous	NULL
sequences	NULL
that	NULL
do	NULL
not	NULL
bind	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
nuclear	NULL
extracts	NULL
are	NULL
labeled	NULL
by	NULL
the	NULL
horizontal	NULL
lines	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
Tagl-XmnI	NULL
fragment	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Motifs	NULL
which	NULL
bind	NULL
nuclear	NULL
factors	NULL
in	NULL
vitro	NULL
are	NULL
boxed	NULL
.	NULL

GT-I	NULL
,	NULL
GT-III	NULL
,	NULL
and	NULL
GT-IV	NULL
,	NULL
which	NULL
do	NULL
not	NULL
bind	NULL
proteins	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
are	NULL
indicated	NULL
by	NULL
underlines	NULL
.	NULL

nuclear	NULL
factor	NULL
binding	NULL
pattern	NULL
in	NULL
vivo	NULL
of	NULL
HS-40	NULL
in	NULL
human	NULL
embryonic	NULL
erythroid	NULL
cells	NULL
,	NULL
adult	NULL
erythroblasts	NULL
,	NULL
and	NULL
nonerythroid	NULL
cells	NULL
would	NULL
reveal	NULL
interesting	NULL
insights	NULL
into	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
different	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
HS-40	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
constructs	NULL
.	NULL

All	NULL
recombinant	NULL
DNA	NULL
work	NULL
was	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

A	NULL
cloning	NULL
vector	NULL
,	NULL
pOGH	NULL
{	NULL
Nichols	NULL
Institute	NULL
)	NULL
,	NULL
was	NULL
used	NULL
to	NULL
construct	NULL
p	NULL
{	NULL
126-GH	NULL
and	NULL
p	NULL
{	NULL
597-GH	NULL
.	NULL

pOGH	NULL
is	NULL
a	NULL
pUC12-based	NULL
plasmid	NULL
containing	NULL
a	NULL
promoterless	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
GH	NULL
)	NULL
gene	NULL
immediately	NULL
downstream	NULL
from	NULL
a	NULL
unique	NULL
BamHI	NULL
site	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Upstream	NULL
of	NULL
the	NULL
BamHI	NULL
site	NULL
is	NULL
a	NULL
polylinker	NULL
.	NULL

p	NULL
{	NULL
126-GH	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
a	NULL
126-bp	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
fragment	NULL
from	NULL
Psfl	NULL
(	NULL
-88	NULL
)	NULL
to	NULL
Pvull	NULL
(	NULL
+38	NULL
)	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pOGH	NULL
.	NULL

p	NULL
{	NULL
S597-GH	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
a	NULL
597-bp	NULL
£2	NULL
globin	NULL
promoter	NULL
fragment	NULL
from	NULL
EcoRI	NULL
(	NULL
-559	NULL
)	NULL
to	NULL
Pvull	NULL
(	NULL
+38	NULL
)	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pOGH	NULL
.	NULL

pHS40-£126-GH	NULL
and	NULL
pHS40-£597-GH	NULL
were	NULL
constructed	NULL
by	NULL
blunt-end	NULL
ligation	NULL
of	NULL
a	NULL
373-bp	NULL
EcoRI-BamHI	NULL
fragment	NULL
,	NULL
isolated	NULL
from	NULL
pXAJa	NULL
«	NULL
and	NULL
containing	NULL
the	NULL
HS-40	NULL
enhancer	NULL
(	NULL
14	NULL
)	NULL
,	NULL
into	NULL
the	NULL
HindIH	NULL
site	NULL
within	NULL
the	NULL
polylinkers	NULL
of	NULL
p	NULL
{	NULL
126-GH	NULL
and	NULL
p	NULL
{	NULL
597-GH	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
HS-40	NULL
enhancer	NULL
sequences	NULL
of	NULL
both	NULL
pHS40-£597-GH	NULL
and	NULL
pHS40-£126-GH	NULL
are	NULL
in	NULL
the	NULL
genomic	NULL
orientation	NULL
with	NULL
respect	NULL
to	NULL
transcriptional	NULL
direction	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
.	NULL

A	NULL
plasmid	NULL
,	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-£597-GH	NULL
,	NULL
was	NULL
also	NULL
isolated	NULL
in	NULL
which	NULL
HS-40	NULL
was	NULL
cloned	NULL
in	NULL
the	NULL
antigenomic	NULL
orientation	NULL
.	NULL

pHS40	NULL
(	NULL
3	NULL
'	NULL
)	NULL
-	NULL
£597-GH	NULL
contains	NULL
the	NULL
HS-40	NULL
enhancer	NULL
cloned	NULL
at	NULL
the	NULL
EcoRI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
GH	NULL
gene	NULL
of	NULL
p	NULL
{	NULL
597-GH	NULL
.	NULL

The	NULL
linear	NULL
maps	NULL
of	NULL
all	NULL
these	NULL
plasmid	NULL
constructs	NULL
are	NULL
diagrammed	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

Plasmid	NULL
clones	NULL
containing	NULL
truncation	NULL
mutants	NULL
of	NULL
HS-40	NULL
upstream	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
were	NULL
constructed	NULL
as	NULL
follows	NULL
.	NULL

A	NULL
653-bp	NULL
helper	NULL
restriction	NULL
fragment	NULL
was	NULL
isolated	NULL
from	NULL
pBR322	NULL
by	NULL
EcoRI	NULL
and	NULL
Sa/l	NULL
codigestion	NULL
,	NULL
blunt	NULL
ended	NULL
with	NULL
Klenow	NULL
enzyme	NULL
,	NULL
and	NULL
then	NULL
ligated	NULL
into	NULL
the	NULL
blunt-ended	NULL
Sall	NULL
site	NULL
of	NULL
plasmids	NULL
pHS40-£597-GH	NULL
and	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-£597-GH	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
resulting	NULL
two	NULL
plasmids	NULL
were	NULL
each	NULL
linearized	NULL
at	NULL
the	NULL
HindIII	NULL
site	NULL
located	NULL
near	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
helper	NULL
fragment	NULL
and	NULL
several	NULL
base	NULL
pairs	NULL
downstream	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
,	NULL
digested	NULL
with	NULL
BalZ31	NULL
exonuclease	NULL
for	NULL
different	NULL
lengths	NULL
of	NULL
time	NULL
,	NULL
recut	NULL
with	NULL
Xbal	NULL
to	NULL
remove	NULL
the	NULL
residual	NULL
helper	NULL
fragment	NULL
,	NULL
blunt	NULL
ended	NULL
with	NULL
Klenow	NULL
enzyme	NULL
,	NULL
circularized	NULL
with	NULL
DNA	NULL
ligase	NULL
,	NULL
and	NULL
then	NULL
transformed	NULL
into	NULL
Escherichia	NULL
coli	NULL
DHSa	NULL
.	NULL

The	NULL
extents	NULL
of	NULL
deletions	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
sequence	NULL
in	NULL
different	NULL
recombinant	NULL
clones	NULL
were	NULL
determined	NULL
by	NULL
dideoxynucleotide	NULL
sequencing	NULL
of	NULL
miniplasmid	NULL
preparations	NULL
with	NULL
the	NULL
M13	NULL
forward	NULL
primer	NULL
and	NULL
the	NULL
Seque-nase	NULL
protocol	NULL
from	NULL
US	NULL
Biochemicals	NULL
.	NULL

The	NULL
above	NULL
strategy	NULL
ensures	NULL
that	NULL
all	NULL
truncated	NULL
forms	NULL
of	NULL
HS-40	NULL
enhancer	NULL
,	NULL
in	NULL
either	NULL
genomic	NULL
or	NULL
antigenomic	NULL
orientation	NULL
,	NULL
are	NULL
flanked	NULL
by	NULL
the	NULL
same	NULL
DNA	NULL
sequences	NULL
.	NULL

Appropriate	NULL
clones	NULL
were	NULL
then	NULL
selected	NULL
,	NULL
and	NULL
plasmid	NULL
DNAs	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
alkaline	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
lysis	NULL
procedures	NULL
and	NULL
CsCl	NULL
equilibrium	NULL
centrifugation	NULL
(	NULL
33	NULL
)	NULL
.	NULL

2300	NULL
ZHANG	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

(	NULL
A	NULL
)	NULL
(	NULL
+210	NULL
)	NULL
(	NULL
+70	NULL
)	NULL
ZFI1	NULL
CP2	NULL
(	NULL
+230	NULL
)	NULL
(	NULL
+150	NULL
)	NULL
_	NULL
(	NULL
-104	NULL
)	NULL
GATA-1	NULL
ZF2	NULL
-	NULL
GATA	NULL
(	NULL
EcoR	NULL
1	NULL
}	NULL
ﬁr	NULL
m	NULL
|	NULL
_	NULL
]	NULL
|	NULL
l	NULL
(	NULL
Pvu	NULL
11	NULL
)	NULL
-559	NULL
+10	NULL
+38	NULL
SP1	NULL
SP1	NULL
SP1	NULL
(	NULL
+241	NULL
)	NULL
(	NULL
+93	NULL
)	NULL
(	NULL
+78	NULL
)	NULL
(	NULL
B	NULL
)	NULL
Growth	NULL
hormone	NULL
concentration	NULL
(	NULL
ng/ml/10	NULL
5	NULL
cells	NULL
)	NULL
cn	NULL
K562	NULL
HeLa	NULL
poGH	NULL
0.9	NULL
&	NULL
0.200	NULL
0.80	NULL
&	NULL
0.1	NULL
-88	NULL
+38	NULL
GH	NULL
p	NULL
126-GH	NULL
3.0	NULL
&	NULL
o.8	NULL
3.20	NULL
a	NULL
0.2	NULL
«	NULL
559	NULL
+38	NULL
GH	NULL
p	NULL
{	NULL
597-GH	NULL
3.6	NULL
@	NULL
0.8	NULL
3.60	NULL
%	NULL
4.7	NULL
<	NULL
—	NULL
]	NULL
GH	NULL
pHS40-	NULL
4	NULL
126-GH	NULL
suman	NULL
122	NULL
&	NULL
24	NULL
10.9	NULL
&	NULL
0.6	NULL
GH	NULL
pHS40-	NULL
§	NULL
597-GH	NULL
it—	NULL
680	NULL
&	NULL
r20	NULL
10.2	NULL
%	NULL
1.2	NULL
S	NULL
Z	NULL
GH	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-	NULL
{	NULL
597-GH	NULL
650	NULL
a	NULL
ors	NULL
ND	NULL
--	NULL
t	NULL
GH	NULL
pHS40	NULL
(	NULL
3	NULL
'	NULL
)	NULL
-	NULL
[	NULL
597-.GH	NULL
A	NULL
700	NULL
«	NULL
190	NULL
ND	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
binding	NULL
sites	NULL
of	NULL
nuclear	NULL
factors	NULL
within	NULL
the	NULL
£2	NULL
globin	NULL
upstream	NULL
promoter	NULL
.	NULL

Nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
within	NULL
250	NULL
bp	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
upstream	NULL
promoter	NULL
region	NULL
,	NULL
as	NULL
mapped	NULL
by	NULL
protein-DNA	NULL
binding	NULL
studies	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
43	NULL
)	NULL
,	NULL
are	NULL
indicated	NULL
by	NULL
black	NULL
boxes	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
central	NULL
nucleotides	NULL
of	NULL
each	NULL
motif	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
initiation	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
,	NULL
are	NULL
indicated	NULL
in	NULL
the	NULL
parentheses	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transient	NULL
expression	NULL
assay	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
and	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
.	NULL

Various	NULL
plasmid	NULL
constructs	NULL
containing	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
(	NULL
shadowed	NULL
bars	NULL
)	NULL
-human	NULL
GH	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
hybrid	NULL
genes	NULL
and	NULL
the	NULL
HS-40	NULL
enhancer	NULL
fragment	NULL
(	NULL
represented	NULL
by	NULL
the	NULL
arrows	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
or	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
promoter	NULL
activities	NULL
were	NULL
measured	NULL
by	NULL
the	NULL
GH	NULL
assay	NULL
at	NULL
48	NULL
h	NULL
posttransfection	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
growth	NULL
hormone	NULL
in	NULL
the	NULL
media	NULL
are	NULL
expressed	NULL
as	NULL
nanograms	NULL
per	NULL
milliliter	NULL
per	NULL
10°	NULL
transfected	NULL
cells	NULL
after	NULL
normalization	NULL
against	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activities	NULL
of	NULL
cotransfected	NULL
pSV2-CAT	NULL
plasmid	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

For	NULL
more	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Plasmids	NULL
p	NULL
{	NULL
597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
and	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
are	NULL
similar	NULL
to	NULL
p£	NULL
{	NULL
597-GH	NULL
and	NULL
pHS40-£597-GH	NULL
,	NULL
respectively	NULL
,	NULL
except	NULL
that	NULL
the	NULL
distal	NULL
GATA-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
of	NULL
the	NULL
former	NULL
plasmids	NULL
has	NULL
been	NULL
changed	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
text	NULL
)	NULL
.	NULL

Plasmid	NULL
pHS40-	NULL
{	NULL
597	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-GH	NULL
is	NULL
similar	NULL
to	NULL
pHS40-£597-GH	NULL
,	NULL
except	NULL
that	NULL
the	NULL
proximal	NULL
GATA-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
£2	NULL
globin	NULL
promoter	NULL
of	NULL
the	NULL
former	NULL
plasmid	NULL
has	NULL
been	NULL
changed	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Plasmid	NULL
pHS40	NULL
(	NULL
r-mt	NULL
1	NULL
)	NULL
-£597-GH	NULL
is	NULL
similar	NULL
to	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-£597-GH	NULL
except	NULL
that	NULL
the	NULL
3°	NULL
NF-E2/AP1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
HS-40	NULL
of	NULL
pHS40	NULL
(	NULL
r-mt	NULL
1	NULL
)	NULL
-£597-GH	NULL
has	NULL
been	NULL
mutated	NULL
by	NULL
mutagenesis	NULL
.	NULL

Plasmid	NULL
pHS40	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-£597-GH	NULL
is	NULL
similar	NULL
to	NULL
pHS40-£597-GH	NULL
except	NULL
that	NULL
its	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
has	NULL
been	NULL
mutagenized	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
text	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
was	NULL
achieved	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
[	NULL
pBluescript	NULL
II	NULL
KS	NULL
(	NULL
-	NULL
)	NULL
;	NULL
Stratagene	NULL
]	NULL
.	NULL

Candidate	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
to	NULL
be	NULL
mutated	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pBluescript	NULL
II	NULL
KS	NULL
(	NULL
-	NULL
)	NULL
vector	NULL
,	NULL
and	NULL
mutagenesis	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specification	NULL
.	NULL

The	NULL
oligonucleotide	NULL
primers	NULL
5-GGGTGGGGCCCCGAGCTCT	NULL
CCTAGACTCTG-3	NULL
'	NULL
and	NULL
5-CACTGGATCTAGAAAGAAA	NULL
CACCAC-3	NULL
'	NULL
were	NULL
used	NULL
for	NULL
mutagenesis	NULL
of	NULL
the	NULL
distal	NULL
and	NULL
proximal	NULL
GATA-1	NULL
binding	NULL
sites	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
oligonucleotide	NULL
primers	NULL
5-GATGACTCAGAAG	NULL
TCCTGTTGG-3	NULL
'	NULL
and	NULL
5-GTTGGCCCAGAATTCTGCTCCC	NULL
TCAAGT-3	NULL
'	NULL
were	NULL
used	NULL
to	NULL
mutagenize	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
and	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motifs	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
verification	NULL
by	NULL
DNA	NULL
sequencing	NULL
,	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
mutated	NULL
sites	NULL
were	NULL
cut	NULL
out	NULL
from	NULL
pBluescript	NULL
II	NULL
KS	NULL
(	NULL
-	NULL
)	NULL
and	NULL
cloned	NULL
back	NULL
into	NULL
the	NULL
appropriate	NULL
vectors	NULL
to	NULL
form	NULL
p£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
,	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
,	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-GH	NULL
,	NULL
pHS40	NULL
(	NULL
r-mt	NULL
1	NULL
)	NULL
-£597-GH	NULL
,	NULL
and	NULL
pHS40	NULL
(	NULL
mt	NULL
.	NULL

2	NULL
)	NULL
-£597-GH	NULL
,	NULL
respectively	NULL
.	NULL

DNA	NULL
transfection	NULL
of	NULL
cell	NULL
cultures	NULL
.	NULL

Erythroid	NULL
K562	NULL
cells	NULL
,	NULL
lymphoid	NULL
Raji	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
nonerythroid	NULL
HeLa	NULL
cells	NULL
were	NULL
cultured	NULL
under	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
0.1	NULL
M	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic	NULL
acid	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
50	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
50	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
(	NULL
all	NULL
from	NULL
GIBCO	NULL
)	NULL
.	NULL

For	NULL
DNA	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
densities	NULL
of	NULL
0.7	NULL
x	NULL
10°	NULL
to	NULL
1.2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
resuspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
5	NULL
ug	NULL
of	NULL
test	NULL
plasmids	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
pSV2-CAT	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
35	NULL
pg	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
as	NULL
a	NULL
carrier	NULL
.	NULL

DNA	NULL
transfection	NULL
was	NULL
done	NULL
by	NULL
electroporation	NULL
(	NULL
29	NULL
)	NULL
in	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
at	NULL
a	NULL
capacity	NULL
of	NULL
960	NULL
mF	NULL
and	NULL
appropriate	NULL
voltages	NULL
:	NULL
300	NULL
V	NULL
for	NULL
K562	NULL
and	NULL
350	NULL
V	NULL
for	NULL
HeLa	NULL
cells	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
100-mm	NULL
petri	NULL
dishes	NULL
.	NULL

For	NULL
each	NULL
plasmid	NULL
construct	NULL
,	NULL
three	NULL
or	NULL
more	NULL
DNA	NULL
transfection	NULL
experiments	NULL
were	NULL
done	NULL
to	NULL
obtain	NULL
average	NULL
values	NULL
of	NULL
the	NULL
promoter	NULL
activities	NULL
.	NULL

GH	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assays	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
DNA	NULL
transfection	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
human	NULL
GH	NULL
secreted	NULL
into	NULL
the	NULL
media	NULL
by	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
quan-titated	NULL
with	NULL
the	NULL
Allegro	NULL
hGH	NULL
radioimmunoassay	NULL
kit	NULL
from	NULL
Nichols	NULL
Institute	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Samples	NULL
and	NULL
standards	NULL
were	NULL
diluted	NULL
eightfold	NULL
with	NULL
horse	NULL
serum	NULL
to	NULL
lower	NULL
the	NULL
biotin	NULL
concentration	NULL
in	NULL
the	NULL
RPMI	NULL
1640	NULL
medium	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommended	NULL
values	NULL
.	NULL

When	NULL
the	NULL
concentrations	NULL
of	NULL
GH	NULL
in	NULL
the	NULL
medium	NULL
exceeded	NULL
50	NULL
ng/ml	NULL
,	NULL
further	NULL
dilutions	NULL
were	NULL
done	NULL
to	NULL
obtain	NULL
a	NULL
linear	NULL
range	NULL
for	NULL
the	NULL
hGH	NULL
assay	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
were	NULL
checked	NULL
by	NULL
measuring	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
enzyme	NULL
activities	NULL
in	NULL
extracts	NULL
of	NULL
transfected	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

Cytoplas-	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
mic	NULL
RNAs	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
described	NULL
in	NULL
reference	NULL
16	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
from	NULL
each	NULL
transfection	NULL
experiment	NULL
were	NULL
harvested	NULL
after	NULL
48	NULL
h	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
cold	NULL
(	NULL
4°C	NULL
)	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
with	NULL
0.6	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
0.65	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
kept	NULL
in	NULL
ice	NULL
for	NULL
1	NULL
to	NULL
5	NULL
min	NULL
and	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
3,000	NULL
rpm	NULL
and	NULL
4°C	NULL
in	NULL
an	NULL
Eppendorf	NULL
Microfuge	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
fresh	NULL
Eppendorf	NULL
tube	NULL
and	NULL
mixed	NULL
with	NULL
0.6	NULL
ml	NULL
of	NULL
7	NULL
M	NULL
urea-10	NULL
mM	NULL
EDTA-350	NULL
mM	NULL
NaCl-1	NULL
%	NULL
SDS-10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

RNA	NULL
pellets	NULL
were	NULL
dissolved	NULL
in	NULL
50	NULL
to	NULL
100	NULL
ul	NULL
of	NULL
diethyl	NULL
pyrocarbonate	NULL
(	NULL
DEPC	NULL
)	NULL
-treated	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
their	NULL
qualities	NULL
and	NULL
quantities	NULL
were	NULL
analyzed	NULL
by	NULL
spectrophotometric	NULL
measurement	NULL
of	NULL
a	NULL
diluted	NULL
aliquot	NULL
as	NULL
well	NULL
as	NULL
by	NULL
electrophoresis	NULL
on	NULL
denaturing	NULL
formaldehyde	NULL
gels	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
{	NULL
-GH	NULL
hybrid	NULL
RNAs	NULL
from	NULL
enhancer-carrying	NULL
plasmids	NULL
in	NULL
transfected	NULL
K562	NULL
cells	NULL
was	NULL
done	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
(	NULL
33	NULL
)	NULL
with	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
sense	NULL
strand	NULL
of	NULL
the	NULL
human	NULL
GH	NULL
gene	NULL
:	NULL
5'-TGGTTCGGGGAGTTGGGCCTTGGGATC-3	NULL
'	NULL
.	NULL

As	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
the	NULL
primer	NULL
extension	NULL
reactions	NULL
also	NULL
included	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
that	NULL
would	NULL
hybridize	NULL
to	NULL
and	NULL
be	NULL
extended	NULL
on	NULL
the	NULL
endogenous	NULL
human	NULL
£2	NULL
globin	NULL
transcripts	NULL
:	NULL
5'-GACACAATGATGGTCCTCTCAGTCTITGGTCAGAGA-3	NULL
'	NULL
.	NULL

The	NULL
expected	NULL
extension	NULL
products	NULL
from	NULL
the	NULL
{	NULL
-GH	NULL
hybrid	NULL
RNA	NULL
and	NULL
endogenous	NULL
{	NULL
globin	NULL
RNA	NULL
are	NULL
64	NULL
and	NULL
93	NULL
nucleotides	NULL
long	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
vivo	NULL
DMS	NULL
footprinting	NULL
.	NULL

Genomic	NULL
footprinting	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
in	NULL
intact	NULL
cells	NULL
was	NULL
done	NULL
by	NULL
ligation-mediated	NULL
polymerase	NULL
chain	NULL
reaction	NULL
according	NULL
to	NULL
references	NULL
23	NULL
and	NULL
26	NULL
with	NULL
some	NULL
modifications	NULL
(	NULL
30	NULL
)	NULL
.	NULL

K562	NULL
,	NULL
Raji	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
log	NULL
phase	NULL
of	NULL
growth	NULL
and	NULL
treated	NULL
with	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
DMS	NULL
;	NULL
Fluka	NULL
)	NULL
.	NULL

Lymphocytes	NULL
from	NULL
human	NULL
blood	NULL
were	NULL
isolated	NULL
by	NULL
Histopaque	NULL
(	NULL
Sigma	NULL
)	NULL
gradient	NULL
centrifugation	NULL
(	NULL
3	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
and	NULL
treated	NULL
with	NULL
DMS	NULL
.	NULL

To	NULL
analyze	NULL
genomic	NULL
footprints	NULL
in	NULL
nucleated	NULL
adult	NULL
erythroblasts	NULL
,	NULL
adult	NULL
human	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
iliac	NULL
crest	NULL
aspiration	NULL
from	NULL
a	NULL
homozygous	NULL
sickle	NULL
cell	NULL
volunteer	NULL
donor	NULL
.	NULL

Buffy	NULL
coat	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
subjected	NULL
to	NULL
direct	NULL
immune	NULL
adherence	NULL
,	NULL
using	NULL
Falcon	NULL
petri	NULL
dishes	NULL
precoated	NULL
with	NULL
monoclonal	NULL
antibody	NULL
23.6*	NULL
,	NULL
which	NULL
is	NULL
specific	NULL
for	NULL
CFU-E	NULL
(	NULL
erythroblast	NULL
)	NULL
,	NULL
erythroblasts	NULL
,	NULL
and	NULL
erythrocytes	NULL
.	NULL

The	NULL
adherent	NULL
cell	NULL
population	NULL
collected	NULL
consisted	NULL
of	NULL
approximately	NULL
60	NULL
%	NULL
erythrocytes	NULL
and	NULL
40	NULL
%	NULL
erythroblasts	NULL
.	NULL

Of	NULL
the	NULL
nucleated	NULL
cells	NULL
,	NULL
90	NULL
%	NULL
were	NULL
erythroblasts	NULL
;	NULL
approximately	NULL
10	NULL
%	NULL
were	NULL
various	NULL
classes	NULL
of	NULL
nonerythroid	NULL
marrow	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
and	NULL
treated	NULL
with	NULL
DMS	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Genomic	NULL
DNAs	NULL
were	NULL
prepared	NULL
by	NULL
standard	NULL
methods	NULL
(	NULL
33	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
purified	NULL
K562	NULL
or	NULL
HeLa	NULL
DNA	NULL
was	NULL
empirically	NULL
treated	NULL
in	NULL
vitro	NULL
with	NULL
DMS	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
.	NULL

DNA	NULL
samples	NULL
treated	NULL
in	NULL
vivo	NULL
or	NULL
in	NULL
vitro	NULL
with	NULL
DMS	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
B-elimination	NULL
cleavage	NULL
reaction	NULL
with	NULL
1	NULL
M	NULL
piperidine	NULL
(	NULL
Aldrich	NULL
)	NULL
to	NULL
cleave	NULL
at	NULL
the	NULL
methylated	NULL
G	NULL
residues	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
frozen	NULL
and	NULL
lyophilized	NULL
under	NULL
high	NULL
vac-uum	NULL
.	NULL

Trace	NULL
amounts	NULL
of	NULL
piperidine	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
and	NULL
lyophilizing	NULL
samples	NULL
two	NULL
to	NULL
three	NULL
times	NULL
with	NULL
deionized	NULL
water	NULL
and	NULL
finally	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

Piperidine-cleaved	NULL
DNA	NULL
fragments	NULL
(	NULL
2	NULL
to	NULL
3	NULL
mg	NULL
)	NULL
were	NULL
hybridized	NULL
with	NULL
target-specific	NULL
oligonucleotide	NULL
primer	NULL
set	NULL
A	NULL
or	NULL
B	NULL
and	NULL
then	NULL
amplified	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

The	NULL
final	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
7	NULL
M	NULL
urea-6	NULL
%	NULL
polyacryl-amide	NULL
gels	NULL
and	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
ENHANCER-PROMOTER	NULL
INTERACTION	NULL
OF	NULL
HUMAN	NULL
{	NULL
2	NULL
GLOBIN	NULL
GENE	NULL
2301	NULL
repeated	NULL
with	NULL
three	NULL
or	NULL
more	NULL
separate	NULL
batches	NULL
of	NULL
DMS-treated	NULL
cells	NULL
to	NULL
ensure	NULL
the	NULL
reproducibility	NULL
of	NULL
the	NULL
genomic	NULL
footprinting	NULL
data	NULL
.	NULL

Primer	NULL
set	NULL
A	NULL
(	NULL
Al	NULL
,	NULL
5-TCAGGCTTTGCCCCTGAA	NULL
GC-3	NULL
'	NULL
;	NULL
A2	NULL
,	NULL
5	NULL
!	NULL

-AGGCTTTGCCCCTGAAGCCTGGCTGT-3	NULL
'	NULL
;	NULL
A3	NULL
,	NULL
5-GGCTGTGAACACTITTGGGCATGG-3	NULL
'	NULL
)	NULL
and	NULL
primer	NULL
set	NULL
B	NULL
(	NULL
B1	NULL
,	NULL
5-AGCACATCTGCCCAAGCCA-3	NULL
'	NULL
;	NULL
B2	NULL
,	NULL
5'-AAGCCAAGGGTGGAGGCATGCAGC-3	NULL
'	NULL
;	NULL
B3	NULL
,	NULL
5-GGCAT	NULL
GCAGCTGTGGGGGTCTGT-3	NULL
'	NULL
)	NULL
were	NULL
used	NULL
for	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strands	NULL
,	NULL
respectively	NULL
.	NULL

RESULTS	NULL
Erythroid	NULL
lineage-specific	NULL
activation	NULL
of	NULL
human	NULL
£2	NULL
globin	NULL
promoter	NULL
activity	NULL
by	NULL
HS-40	NULL
enhancer	NULL
.	NULL

Previous	NULL
expression	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
presence	NULL
in	NULL
cis	NULL
of	NULL
HS-40	NULL
confers	NULL
high-level	NULL
erythroid	NULL
tissue-specific	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
adult	NULL
a	NULL
globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
when	NULL
stably	NULL
integrated	NULL
into	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
embryonic	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
can	NULL
also	NULL
be	NULL
activated	NULL
by	NULL
HS-40	NULL
in	NULL
an	NULL
erythroid	NULL
cell-specific	NULL
manner	NULL
,	NULL
we	NULL
did	NULL
transient	NULL
expression	NULL
analysis	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
with	NULL
and	NULL
without	NULL
the	NULL
presence	NULL
in	NULL
cis	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

To	NULL
start	NULL
this	NULL
,	NULL
two	NULL
different	NULL
human	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
fragments	NULL
spanning	NULL
sequences	NULL
from	NULL
-88	NULL
to	NULL
+38	NULL
and	NULL
from	NULL
-559	NULL
to	NULL
+38	NULL
were	NULL
individually	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
cloning	NULL
vector	NULL
pOGH	NULL
.	NULL

The	NULL
resulting	NULL
plasmids	NULL
,	NULL
and	NULL
p	NULL
{	NULL
597-GH	NULL
,	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
erythroid	NULL
K562	NULL
and	NULL
nonerythroid	NULL
HeLa	NULL
cell	NULL
cultures	NULL
.	NULL

At	NULL
48	NULL
h	NULL
posttransfection	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
GH	NULL
secreted	NULL
into	NULL
the	NULL
media	NULL
were	NULL
measured	NULL
by	NULL
radioimmunoassay	NULL
.	NULL

Average	NULL
values	NULL
from	NULL
multiple	NULL
sets	NULL
of	NULL
transfection	NULL
experiments	NULL
were	NULL
obtained	NULL
after	NULL
normalization	NULL
against	NULL
chloramphenicol	NULL
acetyltransferase	NULL
enzyme	NULL
activities	NULL
expressed	NULL
from	NULL
cotransfected	NULL
pSV2-CAT	NULL
plasmid	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
more	NULL
details	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
597-	NULL
and	NULL
126-bp	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
fragments	NULL
exhibited	NULL
similarly	NULL
low	NULL
levels	NULL
of	NULL
promoter	NULL
activities	NULL
in	NULL
both	NULL
K562	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
cloned	NULL
a	NULL
373-bp	NULL
fragment	NULL
containing	NULL
the	NULL
HS-40	NULL
enhancer	NULL
sequence	NULL
,	NULL
in	NULL
the	NULL
genomic	NULL
orientation	NULL
,	NULL
into	NULL
the	NULL
HindIII	NULL
sites	NULL
of	NULL
p	NULL
{	NULL
126-GH	NULL
and	NULL
Comparison	NULL
of	NULL
GH	NULL
activities	NULL
secreted	NULL
by	NULL
transfected	NULL
K562	NULL
cells	NULL
indicated	NULL
that	NULL
the	NULL
presence	NULL
in	NULL
cis	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
increases	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
597-bp	NULL
£2	NULL
globin	NULL
fragments	NULL
by	NULL
approximately	NULL
175-fold	NULL
and	NULL
that	NULL
of	NULL
the	NULL
126-bp	NULL
fragment	NULL
by	NULL
40-fold	NULL
(	NULL
compare	NULL
pHS40-£597-GH	NULL
with	NULL
p£597-GH	NULL
and	NULL
pHS40-£126-GH	NULL
with	NULL
p	NULL
{	NULL
126-GH	NULL
,	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
presence	NULL
in	NULL
cis	NULL
of	NULL
HS-40	NULL
could	NULL
only	NULL
enhance	NULL
the	NULL
promoter	NULL
activities	NULL
of	NULL
the	NULL
above	NULL
two	NULL
fragments	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
approximately	NULL
threefold	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

That	NULL
HS-40	NULL
functions	NULL
as	NULL
a	NULL
true	NULL
enhancer	NULL
of	NULL
the	NULL
{	NULL
£2	NULL
globin	NULL
promoter	NULL
was	NULL
demonstrated	NULL
by	NULL
transient	NULL
expression	NULL
assay	NULL
of	NULL
plasmids	NULL
in	NULL
which	NULL
HS-40	NULL
was	NULL
placed	NULL
in	NULL
the	NULL
antigenomic	NULL
orientation	NULL
upstream	NULL
of	NULL
the	NULL
promoter	NULL
[	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-	NULL
{	NULL
597-GH	NULL
,	NULL
Fig	NULL
.	NULL

2B	NULL
]	NULL
or	NULL
downstream	NULL
of	NULL
the	NULL
GH	NULL
reporter	NULL
gene	NULL
[	NULL
pHS40	NULL
(	NULL
3	NULL
'	NULL
)	NULL
-£597-GH	NULL
,	NULL
Fig	NULL
.	NULL

2B	NULL
]	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
enhancer	NULL
effects	NULL
of	NULL
HS-40	NULL
in	NULL
K562	NULL
cells	NULL
were	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
pHS40-£597-GH	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
in	NULL
a	NULL
transient	NULL
expression	NULL
assay	NULL
,	NULL
HS-40	NULL
acts	NULL
as	NULL
an	NULL
erythroid	NULL
cell-specific	NULL
enhancer	NULL
,	NULL
and	NULL
it	NULL
potentiates	NULL
high	NULL
levels	NULL
of	NULL
human	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
in	NULL
an	NULL
orientation-	NULL
and	NULL
position-independent	NULL
manner	NULL
.	NULL

Both	NULL
GATA-1	NULL
factor	NULL
binding	NULL
motifs	NULL
of	NULL
the	NULL
£2	NULL
globin	NULL
promoter	NULL
act	NULL
as	NULL
erythroid-specific	NULL
enhancer-responsive	NULL
elements	NULL
.	NULL

The	NULL
observed	NULL
enhancer	NULL
effect	NULL
of	NULL
HS-40	NULL
on	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
is	NULL
most	NULL
likely	NULL
modulated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
multiple	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
formed	NULL
at	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
nuclear	NULL
factor-DNA	NULL
interaction	NULL
of	NULL
the	NULL
upstream	NULL
promoter	NULL
2302	NULL
ZHANG	NULL
ET	NULL
AL	NULL
.	NULL

237	NULL
224	NULL
A	NULL
|	NULL
wild	NULL
type	NULL
5	NULL
'	NULL
-	NULL
GCCCCTATCTCTCC-	NULL
3	NULL
mutant	NULL
1	NULL
-	NULL
GCCCCgAgCTCTCC-	NULL
3	NULL
GH	NULL
activity	NULL
B	NULL
(	NULL
ng/m1/10	NULL
°	NULL
K562	NULL
cells	NULL
)	NULL
pC	NULL
597-GH	NULL
3.6	NULL
&	NULL
0.8	NULL
p	NULL
S	NULL
597	NULL
(	NULL
mt1	NULL
)	NULL
-GH	NULL
3.7	NULL
&	NULL
0.7	NULL
pHS40-	NULL
{	NULL
597-GH	NULL
675	NULL
%	NULL
119	NULL
pHS40-	NULL
G	NULL
597	NULL
(	NULL
mt1	NULL
)	NULL
-GH	NULL
269	NULL
£	NULL
36	NULL
<	NULL
-	NULL
9	NULL
<	NULL
-	NULL
7¢	NULL
<	NULL
-	NULL
67	NULL
-on	NULL
-+-	NULL
-	NULL
#	NULL
#	NULL
ban	NULL
f	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Transient	NULL
expression	NULL
analysis	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
distal	NULL
GATA-1	NULL
binding	NULL
motif	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
comparison	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
{	NULL
2	NULL
globin	NULL
upstream	NULL
promoters	NULL
in	NULL
regions	NULL
surrounding	NULL
the	NULL
distal	NULL
GATA-1	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
GH	NULL
assay	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
1	NULL
{	NULL
2	NULL
globin	NULL
upstream	NULL
promoter	NULL
activities	NULL
,	NULL
with	NULL
or	NULL
without	NULL
the	NULL
presence	NULL
in	NULL
cis	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Primer	NULL
extension	NULL
assay	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
of	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
pHS40-£597-GH	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Endogenous	NULL
{	NULL
globin	NULL
mRNAs	NULL
gave	NULL
primer	NULL
extension	NULL
products	NULL
93	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
long	NULL
,	NULL
while	NULL
the	NULL
major	NULL
primer	NULL
extension	NULL
product	NULL
from	NULL
{	NULL
2-GH	NULL
hybrid	NULL
RNAs	NULL
of	NULL
transfected	NULL
plasmids	NULL
is	NULL
64	NULL
nucleotides	NULL
long	NULL
.	NULL

The	NULL
arrows	NULL
on	NULL
the	NULL
right	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
three	NULL
length	NULL
markers	NULL
(	NULL
in	NULL
nucleotides	NULL
)	NULL
.	NULL

region	NULL
of	NULL
human	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
in	NULL
K562	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
43	NULL
)	NULL
.	NULL

It	NULL
was	NULL
demonstrated	NULL
that	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
upstream	NULL
promoter	NULL
consists	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factor	NULL
CP	NULL
2	NULL
at	NULL
-70	NULL
,	NULL
GATA-1	NULL
at	NULL
-104	NULL
and	NULL
-230	NULL
,	NULL
Spl	NULL
at	NULL
-240	NULL
,	NULL
ZF	NULL
1	NULL
at	NULL
-210	NULL
,	NULL
and	NULL
ZF	NULL
2	NULL
at	NULL
-150	NULL
(	NULL
43	NULL
;	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
,	NULL
CP	NULL
2	NULL
,	NULL
ZF	NULL
1	NULL
,	NULL
ZF	NULL
2	NULL
,	NULL
and	NULL
Spl	NULL
are	NULL
ubiquitous	NULL
factors	NULL
present	NULL
in	NULL
K562	NULL
and	NULL
HeLa	NULL
extracts	NULL
,	NULL
while	NULL
GATA-1	NULL
is	NULL
restricted	NULL
to	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
.	NULL

We	NULL
chose	NULL
the	NULL
GATA-1	NULL
binding	NULL
sites	NULL
as	NULL
our	NULL
first	NULL
target	NULL
for	NULL
the	NULL
site-directed	NULL
mutagenesis	NULL
experiment	NULL
for	NULL
two	NULL
reasons	NULL
.	NULL

First	NULL
,	NULL
the	NULL
GATA-1	NULL
factor	NULL
is	NULL
erythroid	NULL
specific	NULL
and	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
high	NULL
level	NULL
of	NULL
enhancer-mediated	NULL
activity	NULL
of	NULL
the	NULL
£2	NULL
promoter	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

Second	NULL
,	NULL
each	NULL
of	NULL
the	NULL
two	NULL
GATA-1	NULL
sites	NULL
overlaps	NULL
a	NULL
binding	NULL
site	NULL
of	NULL
Sp1	NULL
,	NULL
and	NULL
dual	NULL
functions	NULL
of	NULL
these	NULL
two	NULL
nuclear	NULL
factors	NULL
have	NULL
been	NULL
proposed	NULL
(	NULL
43	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
function	NULL
of	NULL
the	NULL
distal	NULL
GATA-1	NULL
site	NULL
,	NULL
we	NULL
constructed	NULL
two	NULL
plasmids	NULL
similar	NULL
to	NULL
p	NULL
{	NULL
597-GH	NULL
and	NULL
pHS40-£597-GH	NULL
,	NULL
except	NULL
that	NULL
the	NULL
distal	NULL
GATA-1	NULL
sites	NULL
in	NULL
these	NULL
clones	NULL
were	NULL
mutated	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
two	NULL
mutants	NULL
,	NULL
p	NULL
{	NULL
597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
and	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
,	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
their	NULL
expression	NULL
levels	NULL
were	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
plasmids	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
the	NULL
GH	NULL
assay	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
p	NULL
{	NULL
£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
p	NULL
{	NULL
597-GH	NULL
but	NULL
that	NULL
of	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
is	NULL
only	NULL
about	NULL
40	NULL
%	NULL
that	NULL
of	NULL
the	NULL
wild	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

FIG	NULL
.	NULL

4	NULL
.	NULL

Transient	NULL
expression	NULL
analysis	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
proximal	NULL
GATA-1	NULL
binding	NULL
motif	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
comparison	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
{	NULL
2	NULL
globin	NULL
upstream	NULL
promoters	NULL
in	NULL
regions	NULL
surrounding	NULL
the	NULL
proximal	NULL
GATA-1	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Primer	NULL
extension	NULL
assay	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
of	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
pHS40-£597-GH	NULL
(	NULL
lane	NULL
wt	NULL
)	NULL
,	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-GH	NULL
(	NULL
lane	NULL
mt2	NULL
)	NULL
,	NULL
and	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
1	NULL
)	NULL
-GH	NULL
(	NULL
lane	NULL
mtl	NULL
)	NULL
.	NULL

nt	NULL
,	NULL
nucleotides	NULL
.	NULL

type	NULL
pHS40-£597-GH	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
result	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
of	NULL
RNA	NULL
isolated	NULL
from	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
the	NULL
distal	NULL
GATA-1	NULL
binding	NULL
site	NULL
is	NULL
an	NULL
essential	NULL
HS-40	NULL
enhancer-responsive	NULL
promoter	NULL
element	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
,	NULL
although	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
function	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
proximal	NULL
GATA-1	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
appeared	NULL
to	NULL
have	NULL
an	NULL
even	NULL
more	NULL
drastic	NULL
effect	NULL
on	NULL
its	NULL
enhancer	NULL
responsiveness	NULL
to	NULL
HS-40	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
GH	NULL
mRNA	NULL
level	NULL
in	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
pHS40-£597	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-GH	NULL
is	NULL
only	NULL
approximately	NULL
15	NULL
%	NULL
that	NULL
of	NULL
those	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
plasmid	NULL
pHS40-£597-GH	NULL
.	NULL

Functional	NULL
domains	NULL
of	NULL
HS-40	NULL
enhancer	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
£2	NULL
globin	NULL
promoter	NULL
.	NULL

Previous	NULL
sequence	NULL
analysis	NULL
(	NULL
14	NULL
)	NULL
of	NULL
the	NULL
355-bp	NULL
HS-40	NULL
enhancer-containing	NULL
region	NULL
has	NULL
revealed	NULL
three	NULL
sequence	NULL
motifs	NULL
with	NULL
the	NULL
binding	NULL
consensus	NULL
5-GATA-3	NULL
'	NULL
of	NULL
the	NULL
GATA-1	NULL
nuclear	NULL
factor	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
7	NULL
and	NULL
25	NULL
)	NULL
,	NULL
three	NULL
motifs	NULL
of	NULL
the	NULL
pentanucleotide	NULL
GGTGG	NULL
that	NULL
could	NULL
be	NULL
recognized	NULL
by	NULL
multiple	NULL
nuclear	NULL
factors	NULL
(	NULL
40	NULL
)	NULL
,	NULL
one	NULL
GTGG	NULL
sequence	NULL
,	NULL
and	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
hepta-nucleotide	NULL
sequence	NULL
5'-TGAGTCA-3	NULL
'	NULL
that	NULL
could	NULL
bind	NULL
NF-E2	NULL
or	NULL
API	NULL
(	NULL
1	NULL
,	NULL
17	NULL
,	NULL
20	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Further	NULL
nuclear	NULL
factor-DNA	NULL
binding	NULL
in	NULL
vitro	NULL
indicated	NULL
that	NULL
the	NULL
three	NULL
GATA-1	NULL
motifs	NULL
mentioned	NULL
above	NULL
[	NULL
GATA-1	NULL
(	NULL
a	NULL
)	NULL
,	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
(	NULL
d	NULL
)	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
]	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
5-GATT-3	NULL
'	NULL
motif	NULL
[	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
}	NULL
,	NULL
indeed	NULL
bind	NULL
GATA-1	NULL
factor	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
erythroid	NULL
HEL	NULL
or	NULL
K562	NULL
cells	NULL
.	NULL

Of	NULL
the	NULL
four	NULL
GT	NULL
motifs	NULL
(	NULL
GT	NULL
-I	NULL
through	NULL
-IV	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
however	NULL
,	NULL
only	NULL
GT-II	NULL
binds	NULL
two	NULL
ubiquitous	NULL
nuclear	NULL
factors	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
both	NULL
NF-E2/AP1	NULL
motifs	NULL
,	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
could	NULL
bind	NULL
nuclear	NULL
factor	NULL
NF-E2	NULL
or	NULL
API	NULL
in	NULL
vitro	NULL
(	NULL
14	NULL
,	NULL
37	NULL
)	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Bal	NULL
31	NULL
deletion	NULL
mapping	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
one	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
above	NULL
motifs	NULL
participates	NULL
in	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
HS-40	NULL
,	NULL
we	NULL
constructed	NULL
two	NULL
series	NULL
of	NULL
Bal	NULL
31	NULL
deletion	NULL
clones	NULL
from	NULL
plasmids	NULL
pHS40-£597-GH	NULL
and	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-£597-GH	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

In	NULL
these	NULL
deletion	NULL
clones	NULL
,	NULL
the	NULL
HS-40	NULL
enhancer	NULL
was	NULL
truncated	NULL
from	NULL
either	NULL
the	NULL
3	NULL
'	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
ENHANCER-PROMOTER	NULL
INTERACTION	NULL
OF	NULL
HUMAN	NULL
{	NULL
2	NULL
GLOBIN	NULL
GENE	NULL
2303	NULL
Relative	NULL
Expression	NULL
(	NULL
%	NULL
)	NULL
clone	NULL
No	NULL
355	NULL
100	NULL
(	NULL
wi	NULL
)	NULL
106	NULL
&	NULL
08	NULL
0	NULL
d	NULL
2*	NULL
244	NULL
90	NULL
&	NULL
16	NULL
2	NULL
234	NULL
85	NULL
%	NULL
14	NULL
3	NULL
mm	NULL
38	NULL
a	NULL
oB	NULL
4	NULL
30	NULL
a	NULL
s	NULL
f	NULL
182192	NULL
27	NULL
&	NULL
11	NULL
6	NULL
180	NULL
30	NULL
&	NULL
7	NULL
7	NULL
150	NULL
«	NULL
-=	NULL
8	NULL
19	NULL
-	NULL
9	NULL
200	NULL
205	NULL
160—168	NULL
184—188	NULL
16	NULL
21	NULL
6a	NULL
so	NULL
111	NULL
116	NULL
129	NULL
137	NULL
178	NULL
18200	NULL
ait	NULL
22	NULL
0	NULL
252287	NULL
_	NULL
0A	NULL
a_	NULL
__	NULL
__	NULL
0	NULL
A	NULL
Im	NULL
A	NULL
3585	NULL
(	NULL
a	NULL
)	NULL
GT	NULL
(	NULL
b	NULL
)	NULL
-	NULL
SNP-E2	NULL
3NPEI	NULL
-	NULL
GT	NULL
(	NULL
©	NULL
(	NULL
a	NULL
)	NULL
GATA	NULL
GATA-L	NULL
/APL	NULL
_-	NULL
/APL	NULL
IL	NULL
M	NULL
IV	NULL
GaTAA	NULL
_	NULL
GATA4	NULL
280	NULL
w=	NULL
10	NULL
PJ	NULL
_L	NULL
11	NULL
194	NULL
163	NULL
w=	NULL
12	NULL
138	NULL
36	NULL
&	NULL
0	NULL
50	NULL
13	NULL
45	NULL
&	NULL
0	NULL
g	NULL
14	NULL
119136	NULL
90	NULL
&	NULL
140	NULL
15	NULL
95	NULL
&	NULL
100	NULL
16	NULL
$	NULL
e	NULL
1	NULL
100	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Enhancer	NULL
effects	NULL
of	NULL
truncation	NULL
mutants	NULL
of	NULL
HS-40	NULL
.	NULL

Plasmid	NULL
constructs	NULL
containing	NULL
the	NULL
{	NULL
2-GH	NULL
hybrid	NULL
gene	NULL
and	NULL
the	NULL
HS-40	NULL
enhancer	NULL
sequence	NULL
truncated	NULL
with	NULL
Bal	NULL
31	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
primer	NULL
extension	NULL
assay	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
truncated	NULL
fragments	NULL
of	NULL
HS-40	NULL
contained	NULL
within	NULL
these	NULL
constructs	NULL
are	NULL
represented	NULL
by	NULL
the	NULL
black	NULL
bars	NULL
.	NULL

The	NULL
HS-40	NULL
fragments	NULL
of	NULL
clones	NULL
1	NULL
to	NULL
9	NULL
(	NULL
top	NULL
)	NULL
are	NULL
in	NULL
the	NULL
genomic	NULL
orientation	NULL
,	NULL
and	NULL
those	NULL
of	NULL
clones	NULL
10	NULL
to	NULL
16	NULL
(	NULL
bottom	NULL
)	NULL
are	NULL
antigenomic	NULL
relative	NULL
to	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
in	NULL
the	NULL
plasmids	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
plasmids	NULL
are	NULL
assigned	NULL
as	NULL
100	NULL
%	NULL
.	NULL

(	NULL
clones	NULL
1	NULL
to	NULL
9	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
or	NULL
the	NULL
5	NULL
'	NULL
(	NULL
clones	NULL
10	NULL
to	NULL
16	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
direction	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
by	NULL
electroporation	NULL
,	NULL
and	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activities	NULL
were	NULL
measured	NULL
at	NULL
48	NULL
h	NULL
posttransfection	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
as	NULL
exemplified	NULL
in	NULL
the	NULL
gels	NULL
of	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
different	NULL
Bal	NULL
31	NULL
deletion	NULL
clones	NULL
,	NULL
as	NULL
deduced	NULL
from	NULL
RNA	NULL
analysis	NULL
of	NULL
three	NULL
independent	NULL
sets	NULL
of	NULL
Clone	NULL
No	NULL
.	NULL

wto	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6°	NULL
7	NULL
8	NULL
9	NULL
&	NULL
-	NULL
»	NULL
Wit	NULL
ooo	NULL
whib	NULL
cue	NULL
moe	NULL
Wb	NULL
onic	NULL
wih	NULL
ton-	NULL
»	NULL
(	NULL
B	NULL
)	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Primer	NULL
extension	NULL
assay	NULL
of	NULL
RNA	NULL
transcripts	NULL
of	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
Bal	NULL
31	NULL
deletion	NULL
clones	NULL
.	NULL

Cytoplasmic	NULL
RNAs	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
containing	NULL
{	NULL
2-GH	NULL
hybrid	NULL
gene	NULL
and	NULL
the	NULL
HS-40	NULL
enhancer	NULL
truncated	NULL
to	NULL
different	NULL
extents	NULL
(	NULL
clones	NULL
1	NULL
to	NULL
16	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
were	NULL
purified	NULL
,	NULL
hybridized	NULL
with	NULL
appropriate	NULL
*°P-end-labeled	NULL
oligonucleotides	NULL
,	NULL
and	NULL
extended	NULL
with	NULL
reverse	NULL
transcriptase	NULL
.	NULL

The	NULL
extension	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
denaturing	NULL
gel	NULL
electro-phoresis	NULL
.	NULL

The	NULL
arrows	NULL
of	NULL
{	NULL
and	NULL
{	NULL
-GH	NULL
point	NULL
to	NULL
the	NULL
gel	NULL
positions	NULL
of	NULL
extension	NULL
products	NULL
from	NULL
the	NULL
endogenous	NULL
{	NULL
mRNA	NULL
and	NULL
from	NULL
the	NULL
{	NULL
2-GH	NULL
hybrid	NULL
RNA	NULL
of	NULL
the	NULL
transfected	NULL
plasmids	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiograph	NULL
for	NULL
primer	NULL
extension	NULL
analysis	NULL
of	NULL
clones	NULL
1	NULL
to	NULL
9	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
;	NULL
(	NULL
B	NULL
)	NULL
autoradiograph	NULL
of	NULL
clones	NULL
10	NULL
to	NULL
16	NULL
.	NULL

<	NULL
-	NULL
S-	NULL
GH	NULL
transfection	NULL
experiments	NULL
,	NULL
are	NULL
compared	NULL
with	NULL
the	NULL
wild	NULL
types	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Data	NULL
from	NULL
the	NULL
GH	NULL
assay	NULL
are	NULL
in	NULL
general	NULL
agreement	NULL
with	NULL
the	NULL
primer	NULL
extension	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
stepwise	NULL
deletion	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
indeed	NULL
affected	NULL
the	NULL
expression	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
with	NULL
levels	NULL
of	NULL
expression	NULL
depending	NULL
on	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
deletion	NULL
reaction	NULL
.	NULL

Thus	NULL
,	NULL
comparison	NULL
of	NULL
expression	NULL
levels	NULL
of	NULL
clones	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
indicates	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
the	NULL
HS-40	NULL
enhancer	NULL
to	NULL
function	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
14	NULL
bp	NULL
from	NULL
clone	NULL
3	NULL
,	NULL
which	NULL
removed	NULL
half	NULL
of	NULL
the	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motif	NULL
,	NULL
decreased	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
by	NULL
approximately	NULL
60	NULL
%	NULL
(	NULL
compare	NULL
clone	NULL
4	NULL
with	NULL
clone	NULL
3	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
was	NULL
seen	NULL
in	NULL
clones	NULL
4	NULL
to	NULL
7	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
functional	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motif	NULL
,	NULL
the	NULL
entire	NULL
GT-III	NULL
and	NULL
GT-IV	NULL
motifs	NULL
and	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
GT-II	NULL
motif	NULL
are	NULL
not	NULL
required	NULL
for	NULL
the	NULL
residual	NULL
enhancer	NULL
activity	NULL
of	NULL
HS-40	NULL
(	NULL
see	NULL
further	NULL
discussion	NULL
later	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
GT	NULL
-II	NULL
motif	NULL
together	NULL
with	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
from	NULL
clone	NULL
7	NULL
abolished	NULL
all	NULL
enhancer	NULL
activity	NULL
of	NULL
HS-40	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
compare	NULL
clones	NULL
8	NULL
and	NULL
9	NULL
with	NULL
clone	NULL
7	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Transient	NULL
expression	NULL
analysis	NULL
of	NULL
deletion	NULL
constructs	NULL
with	NULL
the	NULL
antigenomic	NULL
orientation	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
showed	NULL
that	NULL
motifs	NULL
GATA-1	NULL
(	NULL
a	NULL
)	NULL
,	NULL
GT-I	NULL
,	NULL
and	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
were	NULL
not	NULL
required	NULL
for	NULL
HS-40	NULL
enhancer	NULL
activity	NULL
(	NULL
compare	NULL
clones	NULL
15	NULL
and	NULL
16	NULL
with	NULL
the	NULL
wild-type	NULL
clone	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
the	NULL
5	NULL
'	NULL
NF-E2/API	NULL
motif	NULL
from	NULL
clone	NULL
15	NULL
resulted	NULL
in	NULL
a	NULL
drop	NULL
of	NULL
50	NULL
to	NULL
70	NULL
%	NULL
of	NULL
the	NULL
enhancer	NULL
activity	NULL
(	NULL
compare	NULL
clones	NULL
13	NULL
and	NULL
14	NULL
with	NULL
clone	NULL
15	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
motif	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
.	NULL

A	NULL
further	NULL
deletion	NULL
of	NULL
clone	NULL
13	NULL
,	NULL
which	NULL
extended	NULL
3	NULL
bp	NULL
into	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
,	NULL
completely	NULL
abolished	NULL
the	NULL
enhancer	NULL
activity	NULL
(	NULL
compare	NULL
clones	NULL
10	NULL
to	NULL
12	NULL
with	NULL
clone	NULL
13	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

2304	NULL
ZHANG	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
A	NULL
ACTGCTGAGTCATCCTG	NULL
-3	NULL
ACT	NULL
-3	NULL
CAGTTATCTGCTCCCTC	NULL
rCTG	NULL
(	NULL
U	NULL
wo	NULL
wo	NULL
-	NULL
wus	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

RNA	NULL
analysis	NULL
of	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
containing	NULL
a	NULL
site-directed	NULL
mutation	NULL
of	NULL
the	NULL
3°	NULL
NF-E2/AP1	NULL
motif	NULL
or	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

Plasmid	NULL
pHS40	NULL
(	NULL
r-mt	NULL
1	NULL
)	NULL
-£597-GH	NULL
and	NULL
plasmid	NULL
pHS4O0	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-£597-GH	NULL
,	NULL
which	NULL
contain	NULL
mutated	NULL
3°	NULL
NF-E2/AP1	NULL
and	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
the	NULL
HS-40	NULL
region	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
their	NULL
expression	NULL
levels	NULL
were	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
plasmids	NULL
by	NULL
primer	NULL
extension	NULL
assay	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
comparison	NULL
of	NULL
the	NULL
mutant	NULL
3	NULL
'	NULL
NF-E2/	NULL
AP1	NULL
and	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motifs	NULL
with	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
HS-40	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Primer	NULL
extension	NULL
analysis	NULL
of	NULL
cytoplasmic	NULL
RNAs	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-£597-GH	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
pHS40	NULL
(	NULL
r-mt	NULL
1	NULL
)	NULL
{	NULL
597-GH	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
pHS40-£597-GH	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
pHS40	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
£597-GH	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

nt	NULL
,	NULL
nucleotides	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Site-directed	NULL
mutagenesis	NULL
of	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
and	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motifs	NULL
.	NULL

Data	NULL
from	NULL
the	NULL
above	NULL
Bal	NULL
31	NULL
deletion	NULL
mapping	NULL
analysis	NULL
,	NULL
in	NULL
particular	NULL
those	NULL
of	NULL
the	NULL
clone	NULL
pairs	NULL
7	NULL
and	NULL
8	NULL
and	NULL
12	NULL
and	NULL
13	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
may	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
HS-40	NULL
function	NULL
.	NULL

To	NULL
test	NULL
this	NULL
while	NULL
maintaining	NULL
the	NULL
overall	NULL
integrity	NULL
of	NULL
HS-40	NULL
,	NULL
we	NULL
did	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
introduced	NULL
a	NULL
G-to-T	NULL
substitution	NULL
at	NULL
the	NULL
first	NULL
base	NULL
of	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
base	NULL
substitution	NULL
of	NULL
the	NULL
tandemly	NULL
arranged	NULL
NF-E2/AP1	NULL
motifs	NULL
of	NULL
human	NULL
B	NULL
globin	NULL
locus-specific	NULL
enhancer	NULL
5°	NULL
HS-2	NULL
was	NULL
shown	NULL
to	NULL
completely	NULL
abolish	NULL
the	NULL
5°	NULL
HS-2	NULL
enhancer	NULL
function	NULL
(	NULL
21	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
construct	NULL
with	NULL
the	NULL
above	NULL
point	NULL
mutation	NULL
of	NULL
3	NULL
'	NULL
NF2/AP1	NULL
motif	NULL
,	NULL
pHS40	NULL
(	NULL
r-mt	NULL
1	NULL
)	NULL
-£597-GH	NULL
,	NULL
was	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
level	NULL
was	NULL
compared	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
clone	NULL
pHS40	NULL
(	NULL
r	NULL
)	NULL
-£597-GH	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
the	NULL
point	NULL
mutation	NULL
reduced	NULL
the	NULL
expression	NULL
level	NULL
by	NULL
approximately	NULL
70	NULL
%	NULL
,	NULL
although	NULL
it	NULL
did	NULL
not	NULL
completely	NULL
destroy	NULL
HS-40	NULL
enhancer	NULL
function	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
RNA	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
plasmid	NULL
pHS40	NULL
(	NULL
mt	NULL
2	NULL
)	NULL
-£597-GH	NULL
,	NULL
in	NULL
which	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
of	NULL
HS-40	NULL
was	NULL
modified	NULL
by	NULL
point	NULL
mutagenesis	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
HS-40	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
Bal	NULL
31	NULL
deletion	NULL
data	NULL
of	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
.	NULL

Genomic	NULL
footprinting	NULL
of	NULL
HS-40	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
different	NULL
sequence	NULL
motifs	NULL
in	NULL
HS-40	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
above	NULL
transient	NULL
expression	NULL
analysis	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
are	NULL
modulated	NULL
by	NULL
specific	NULL
nuclear	NULL
factor-	NULL
DNA	NULL
complexes	NULL
formed	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
did	NULL
genomic	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
adult	NULL
erythroblasts	NULL
,	NULL
and	NULL
various	NULL
types	NULL
of	NULL
nonerythroid	NULL
cells	NULL
.	NULL

Intact	NULL
cells	NULL
were	NULL
first	NULL
treated	NULL
with	NULL
DMS	NULL
,	NULL
and	NULL
differences	NULL
in	NULL
the	NULL
methylation	NULL
reactivity	NULL
of	NULL
G	NULL
residues	NULL
in	NULL
vivo	NULL
were	NULL
then	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
protein-free	NULL
DNA	NULL
.	NULL

As	NULL
shown	NULL
below	NULL
,	NULL
erythroid-specific	NULL
footprints	NULL
in	NULL
the	NULL
HS-40	NULL
enhancer	NULL
were	NULL
observed	NULL
at	NULL
both	NULL
of	NULL
the	NULL
NF-E2/AP1	NULL
motifs	NULL
,	NULL
one	NULL
of	NULL
the	NULL
GT	NULL
motifs	NULL
,	NULL
and	NULL
three	NULL
of	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

four	NULL
GATA-1	NULL
motifs	NULL
.	NULL

These	NULL
footprinting	NULL
data	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
and	NULL
9	NULL
and	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

(	NULL
i	NULL
)	NULL
NF-E2/AP1	NULL
motif	NULL
.	NULL

The	NULL
DMS	NULL
footprinting	NULL
pattern	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
HS-40	NULL
shows	NULL
clearly	NULL
that	NULL
both	NULL
NF-E2/API1	NULL
motifs	NULL
are	NULL
protected	NULL
extensively	NULL
in	NULL
the	NULL
two	NULL
types	NULL
of	NULL
erythroid	NULL
cells	NULL
,	NULL
K562	NULL
and	NULL
erythroblasts	NULL
,	NULL
but	NULL
not	NULL
in	NULL
nonerythroid	NULL
cells	NULL
including	NULL
lymphocytes	NULL
,	NULL
HeLa	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

These	NULL
erythroid-specific	NULL
footprints	NULL
are	NULL
manifested	NULL
by	NULL
the	NULL
protections	NULL
of	NULL
residues	NULL
G-130	NULL
,	NULL
G-160	NULL
,	NULL
and	NULL
G-165	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Extensive	NULL
footprints	NULL
were	NULL
also	NULL
observed	NULL
on	NULL
the	NULL
noncoding	NULL
strands	NULL
of	NULL
both	NULL
NF-E2/AP1	NULL
motifs	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
footprinting	NULL
patterns	NULL
of	NULL
the	NULL
5°	NULL
NF-E2/AP1	NULL
are	NULL
different	NULL
between	NULL
the	NULL
two	NULL
types	NULL
of	NULL
erythroid	NULL
cells	NULL
as	NULL
manifested	NULL
by	NULL
the	NULL
significant	NULL
hyperreactivity	NULL
of	NULL
G-134	NULL
and	NULL
the	NULL
almost	NULL
complete	NULL
protection	NULL
of	NULL
G-132	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
GT	NULL
motifs	NULL
.	NULL

Of	NULL
the	NULL
four	NULL
GT	NULL
sequence	NULL
motifs	NULL
,	NULL
only	NULL
one	NULL
of	NULL
them	NULL
binds	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
this	NULL
binding	NULL
is	NULL
erythroid	NULL
cell	NULL
specific	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
lane	NULL
2	NULL
of	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
motif	NULL
GT-II	NULL
and	NULL
its	NULL
5'-flanking	NULL
region	NULL
are	NULL
protected	NULL
extensively	NULL
in	NULL
K562	NULL
cells	NULL
at	NULL
residues	NULL
G-175	NULL
,	NULL
G-176	NULL
,	NULL
G-178	NULL
,	NULL
and	NULL
G-179	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
at	NULL
G-173	NULL
and	NULL
G-177	NULL
.	NULL

The	NULL
protection	NULL
is	NULL
less	NULL
extensive	NULL
in	NULL
the	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
although	NULL
both	NULL
types	NULL
of	NULL
erythroid	NULL
cells	NULL
exhibit	NULL
similar	NULL
levels	NULL
of	NULL
hyperreactivity	NULL
at	NULL
G-182	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
binding	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
GT-II	NULL
motif	NULL
is	NULL
erythroid	NULL
specific	NULL
since	NULL
it	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
lymphocytes	NULL
or	NULL
HeLa	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
to	NULL
8	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
see	NULL
any	NULL
obvious	NULL
footprint	NULL
at	NULL
GT-III	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
,	NULL
GT-IV	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
,	NULL
or	NULL
GT	NULL
-I	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
iil	NULL
)	NULL
GATA-1	NULL
motifs	NULL
.	NULL

Three	NULL
of	NULL
the	NULL
four	NULL
GATA-1	NULL
motifs	NULL
of	NULL
HS-40	NULL
appear	NULL
to	NULL
bind	NULL
nuclear	NULL
factors	NULL
,	NULL
presumably	NULL
GATA-1	NULL
,	NULL
in	NULL
vivo	NULL
in	NULL
an	NULL
erythroid-specific	NULL
manner	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
G-112	NULL
within	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
is	NULL
protected	NULL
in	NULL
both	NULL
K562	NULL
cells	NULL
and	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
but	NULL
not	NULL
in	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
erythroid-specific	NULL
protection	NULL
of	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
hyperreactivity	NULL
of	NULL
G-109	NULL
(	NULL
Fig	NULL
.	NULL

IA	NULL
)	NULL
.	NULL

Nuclear	NULL
factor	NULL
binding	NULL
of	NULL
the	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motif	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
erythroblasts	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
weak	NULL
protection	NULL
of	NULL
G-218	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
with	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
which	NULL
is	NULL
not	NULL
seen	NULL
in	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
other	NULL
nonerythroid	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Protection	NULL
of	NULL
G-250	NULL
immediately	NULL
upstream	NULL
of	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
suggests	NULL
binding	NULL
of	NULL
GATA-1	NULL
factor	NULL
at	NULL
this	NULL
motif	NULL
in	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
,	NULL
lane	NULL
10	NULL
;	NULL
see	NULL
further	NULL
discussion	NULL
later	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
or	NULL
other	NULL
nonerythroid	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
primers	NULL
used	NULL
in	NULL
our	NULL
assay	NULL
did	NULL
not	NULL
allow	NULL
genomic	NULL
footprint	NULL
analysis	NULL
of	NULL
GATA-1	NULL
(	NULL
a	NULL
)	NULL
motif	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
consistently	NULL
observed	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
erythroblasts	NULL
,	NULL
but	NULL
not	NULL
in	NULL
nonerythroid	NULL
cells	NULL
,	NULL
hyperreactivities	NULL
of	NULL
G-234	NULL
and	NULL
G-237	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
and	NULL
G-238	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

9D	NULL
)	NULL
of	NULL
HS-40	NULL
.	NULL

Interestingly	NULL
,	NULL
all	NULL
these	NULL
hyperreactive	NULL
G	NULL
residues	NULL
are	NULL
located	NULL
in	NULL
between	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
and	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motiis	NULL
.	NULL

DISCUSSION	NULL
We	NULL
studied	NULL
the	NULL
functional	NULL
interaction	NULL
between	NULL
human	NULL
£2	NULL
globin	NULL
upstream	NULL
promoter	NULL
and	NULL
the	NULL
a	NULL
globin	NULL
regulatory	NULL
element	NULL
HS-40	NULL
.	NULL

Previous	NULL
expression	NULL
analysis	NULL
in	NULL
stably	NULL
transformed	NULL
cell	NULL
lines	NULL
and	NULL
transgenic	NULL
mice	NULL
has	NULL
shown	NULL
that	NULL
high-level	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
a	NULL
globin	NULL
gene	NULL
in	NULL
adult	NULL
erythroid	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
HS-40	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Our	NULL
transient	NULL
expression	NULL
assay	NULL
demonstrated	NULL
that	NULL
HS-40	NULL
also	NULL
acts	NULL
as	NULL
an	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
(	NULL
A	NULL
)	NULL
coding	NULL
strand	NULL
NK	NULL
E	NULL
L	NULL
1	NULL
2	NULL
3	NULL
4	NULL
119	NULL
aig	NULL
.	NULL

b	NULL
m	NULL
0	NULL
o	NULL
130	NULL
5	NULL
``	NULL
NF-E2/	NULL
H	NULL
API	NULL
gs	NULL
if	NULL
3	NULL
'	NULL
NF-E2/	NULL
H	NULL
f	NULL
o	NULL
10s	NULL
API	NULL
ctu	NULL
[	NULL
§	NULL
GT-	NULL
D/	NULL
188	NULL
119	NULL
-	NULL
®	NULL
ENHANCER-PROMOTER	NULL
INTERACTION	NULL
OF	NULL
HUMAN	NULL
{	NULL
2	NULL
GLOBIN	NULL
GENE	NULL
2305	NULL
(	NULL
B	NULL
)	NULL
noncoding	NULL
strand	NULL
N	NULL
H	NULL
R	NULL
J	NULL
NKE	NULL
£	NULL
;	NULL
;	NULL
841	NULL
;	NULL
j8	NULL
9	NULL
1011	NULL
-o	NULL
sous	NULL
goth	NULL
H	NULL
171	NULL
-	NULL
Wi	NULL
wn	NULL
~	NULL
=	NULL
3	NULL
'	NULL
NF-E2/	NULL
H	NULL
®	NULL
ge	NULL
,	NULL
1+	NULL
API	NULL
«	NULL
»	NULL
we	NULL
us	NULL
o	NULL
o	NULL
161	NULL
wan	NULL
tnd	NULL
cue	NULL
ane	NULL
went	NULL
20	NULL
wen	NULL
wm	NULL
wae	NULL
wo	NULL
ue	NULL
as	NULL
o	NULL
o	NULL
150	NULL
5	NULL
``	NULL
NF-E2/	NULL
H	NULL
#	NULL
m	NULL
oe	NULL
=	NULL
AP1	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

In	NULL
vivo	NULL
DMS	NULL
footprints	NULL
within	NULL
and	NULL
flanking	NULL
NF-E2/AP1	NULL
and	NULL
GT	NULL
motifs	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

Representative	NULL
autoradiographs	NULL
of	NULL
the	NULL
genomic	NULL
footprinting	NULL
analysis	NULL
by	NULL
in	NULL
vivo	NULL
DMS	NULL
protection	NULL
assay	NULL
and	NULL
ligation-mediated	NULL
polymerase	NULL
chain	NULL
reaction	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
top	NULL
and	NULL
bottom	NULL
G	NULL
residues	NULL
of	NULL
each	NULL
autoradiograph	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
left	NULL
according	NULL
to	NULL
the	NULL
numbering	NULL
system	NULL
of	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
different	NULL
motifs	NULL
are	NULL
individually	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
bars	NULL
.	NULL

Protected	NULL
and	NULL
hyperreactive	NULL
Gs	NULL
are	NULL
denoted	NULL
by	NULL
open	NULL
and	NULL
filled	NULL
circles	NULL
,	NULL
respectively	NULL
,	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
each	NULL
autoradiograph	NULL
.	NULL

Sizes	NULL
of	NULL
the	NULL
circles	NULL
indicated	NULL
the	NULL
relative	NULL
extents	NULL
of	NULL
protection	NULL
or	NULL
hyperreactivities	NULL
in	NULL
vivo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Coding	NULL
strand	NULL
;	NULL
(	NULL
B	NULL
)	NULL
noncoding	NULL
strand	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
,	NULL
naked	NULL
DNA	NULL
controls	NULL
(	NULL
N	NULL
)	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
,	NULL
K562	NULL
cells	NULL
(	NULL
K	NULL
)	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
11	NULL
,	NULL
erythroblasts	NULL
(	NULL
E	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
lymphocytes	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
Raji	NULL
cells	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

10.	NULL
enhancer	NULL
for	NULL
human	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
in	NULL
embryonic	NULL
erythroid	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
enhancer-promoter	NULL
interaction	NULL
is	NULL
mediated	NULL
by	NULL
both	NULL
GATA-1	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
within	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
upstream	NULL
promoter	NULL
.	NULL

We	NULL
also	NULL
mapped	NULL
the	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
by	NULL
deletion	NULL
and	NULL
mutagenesis	NULL
experiments	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
functional	NULL
domains	NULL
mapped	NULL
correlate	NULL
well	NULL
with	NULL
motifs	NULL
that	NULL
form	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
embryonic	NULL
erythroid	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
long	NULL
(	NULL
-559	NULL
to	NULL
+38	NULL
)	NULL
and	NULL
short	NULL
(	NULL
-88	NULL
to	NULL
+38	NULL
)	NULL
promoter	NULL
fragments	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
exhibit	NULL
similarly	NULL
low	NULL
level	NULL
of	NULL
promoter	NULL
activities	NULL
in	NULL
either	NULL
erythroid	NULL
K562	NULL
or	NULL
nonerythroid	NULL
HeLa	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
three	NULL
reasons	NULL
for	NULL
this	NULL
observation	NULL
.	NULL

First	NULL
,	NULL
DNA	NULL
sequences	NULL
between	NULL
-559	NULL
and	NULL
-88	NULL
,	NULL
including	NULL
the	NULL
two	NULL
GATA-1	NULL
motifs	NULL
at	NULL
-230	NULL
and	NULL
-104	NULL
,	NULL
ZF	NULL
1	NULL
at	NULL
-210	NULL
,	NULL
and	NULL
ZF	NULL
2	NULL
at	NULL
-150	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
do	NULL
not	NULL
play	NULL
significant	NULL
role	NULL
in	NULL
transient	NULL
expression	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
activity	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Second	NULL
,	NULL
different	NULL
nuclear	NULL
factor	NULL
binding	NULL
sites	NULL
may	NULL
act	NULL
as	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
sequences	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
different	NULL
motifs	NULL
could	NULL
cancel	NULL
each	NULL
other	NULL
.	NULL

A	NULL
third	NULL
possibility	NULL
is	NULL
that	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
indeed	NULL
plays	NULL
a	NULL
function	NULL
role	NULL
,	NULL
but	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
£2	NULL
promoter	NULL
activity	NULL
has	NULL
to	NULL
be	NULL
exerted	NULL
through	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

A	NULL
site-directed	NULL
mutagenesis	NULL
experiment	NULL
with	NULL
the	NULL
GATA-1	NULL
motifs	NULL
at	NULL
-230	NULL
and	NULL
-104	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
provided	NULL
an	NULL
interesting	NULL
example	NULL
of	NULL
the	NULL
third	NULL
scenario	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
motifs	NULL
overlaps	NULL
with	NULL
a	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
Spl	NULL
(	NULL
43	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
GATA-1	NULL
factor	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
HeLa	NULL
cell	NULL
extract	NULL
or	NULL
in	NULL
K562	NULL
cell	NULL
extract	NULL
preincubated	NULL
with	NULL
a	NULL
GATA-1	NULL
factor	NULL
binding	NULL
oligonucleotide	NULL
,	NULL
efficient	NULL
binding	NULL
of	NULL
Spl	NULL
is	NULL
easily	NULL
detected	NULL
.	NULL

However	NULL
,	NULL
when	NULL
GATA-1	NULL
and	NULL
Spl	NULL
factors	NULL
coexist	NULL
,	NULL
binding	NULL
of	NULL
GATA-1	NULL
is	NULL
dominant	NULL
and	NULL
excludes	NULL
further	NULL
binding	NULL
of	NULL
Spl	NULL
.	NULL

Also	NULL
,	NULL
prebound	NULL
Spl	NULL
could	NULL
be	NULL
displaced	NULL
by	NULL
exogenously	NULL
added	NULL
GATA-1	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
indicated	NULL
that	NULL
the	NULL
distal	NULL
set	NULL
of	NULL
overlapping	NULL
GATA-1/Sp1	NULL
sites	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
all	NULL
known	NULL
mammalian	NULL
(	NULL
A	NULL
)	NULL
GATA-1b	NULL
(	NULL
B	NULL
)	NULL
GATA-1¢	NULL
N	NULL
KE	NULL
N	NULL
K	NULL
EL	NULL
12	NULL
3	NULL
100	NULL
_	NULL
4	NULL
.	NULL

8	NULL
.	NULL

07	NULL
75	NULL
-	NULL
ke	NULL
m	NULL
fi	NULL
AP	NULL
tp	NULL
(	NULL
es	NULL
h	NULL
GT-	NULL
IV	NULL
U	NULL
1	NULL
1	NULL
|	NULL
hk	NULL
s	NULL
wit	NULL
Wp	NULL
sae	NULL
o	NULL
o	NULL
205	NULL
t	NULL
>	NULL
as	NULL
as	NULL
us	NULL
:	NULL
am	NULL
GATA-1	NULL
[	NULL
GaTA1	NULL
[	NULL
*	NULL
§	NULL
°	NULL
.	NULL

,	NULL
*	NULL
5	NULL
'NF-E2/	NULL
U	NULL
woe	NULL
0	NULL
0130	NULL
API	NULL
Sota	NULL
did	NULL
433	NULL
__	NULL
«	NULL
--	NULL
«	NULL
ae	NULL
we	NULL
wilt	NULL
0	NULL
.	NULL

0	NULL
231	NULL
136	NULL
fe	NULL
(	NULL
C	NULL
)	NULL
GATA-14	NULL
(	NULL
D	NULL
)	NULL
NKE	NULL
N	NULL
KE	NULL
8	NULL
9	NULL
10	NULL
8s	NULL
9	NULL
10	NULL
231	NULL
-	NULL
=	NULL
247—g	NULL
ix	NULL
“	NULL
;	NULL
o	NULL
o	NULL
234	NULL
MZ	NULL
ee	NULL
238	NULL
thump	NULL
e	NULL
o	NULL
237	NULL
**	NULL
tit	NULL
n	NULL
``	NULL
ans	NULL
GATA-1¢	NULL
[	NULL
]	NULL
®	NULL
some	NULL
wee	NULL
a	NULL
213-	NULL
“	NULL
gm	NULL
o	NULL
250	NULL
%	NULL
GATA-1	NULL
[	NULL
]	NULL
258	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

In	NULL
vivo	NULL
DMS	NULL
footprints	NULL
within	NULL
and	NULL
flanking	NULL
GATA-1	NULL
motifs	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

All	NULL
symbols	NULL
and	NULL
the	NULL
numbering	NULL
system	NULL
are	NULL
the	NULL
same	NULL
as	NULL
those	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Footprinting	NULL
of	NULL
coding	NULL
strand	NULL
containing	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
;	NULL
(	NULL
B	NULL
)	NULL
footprinting	NULL
of	NULL
coding	NULL
strand	NULL
containing	NULL
GT-IV	NULL
and	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motifs	NULL
;	NULL
(	NULL
C	NULL
)	NULL
footprinting	NULL
of	NULL
coding	NULL
strand	NULL
containing	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
;	NULL
(	NULL
D	NULL
)	NULL
footprinting	NULL
of	NULL
noncoding	NULL
strand	NULL
containing	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motif	NULL
.	NULL

N	NULL
,	NULL
naked	NULL
control	NULL
DNA	NULL
;	NULL
K	NULL
,	NULL
K562	NULL
cells	NULL
;	NULL
E	NULL
,	NULL
erythroblasts	NULL
;	NULL
L	NULL
,	NULL
lymphocytes	NULL
.	NULL

2306	NULL
ZHANG	NULL
ET	NULL
AL	NULL
.	NULL

{	NULL
globin	NULL
promoters	NULL
,	NULL
and	NULL
thus	NULL
it	NULL
may	NULL
play	NULL
essential	NULL
function	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
£2	NULL
globin	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
whether	NULL
one	NULL
or	NULL
both	NULL
nuclear	NULL
factors	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
or	NULL
repressor	NULL
in	NULL
embryonic	NULL
and/or	NULL
adult	NULL
erythroid	NULL
cells	NULL
remains	NULL
speculative	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Our	NULL
transient	NULL
expression	NULL
data	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
indicate	NULL
that	NULL
both	NULL
GATA-1	NULL
motifs	NULL
behave	NULL
as	NULL
positive	NULL
regulatory	NULL
sequences	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
in	NULL
the	NULL
embryonic	NULL
and	NULL
fetal	NULL
erythroid	NULL
environment	NULL
and	NULL
that	NULL
at	NULL
least	NULL
the	NULL
distal	NULL
GATA-1	NULL
site	NULL
at	NULL
-230	NULL
does	NULL
so	NULL
only	NULL
when	NULL
the	NULL
HS-40	NULL
enhancer	NULL
is	NULL
present	NULL
in	NULL
cis	NULL
.	NULL

Whether	NULL
other	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
Spl	NULL
at	NULL
-240	NULL
,	NULL
ZF	NULL
1	NULL
at	NULL
-210	NULL
,	NULL
and	NULL
ZF	NULL
2	NULL
at	NULL
-150	NULL
,	NULL
may	NULL
also	NULL
play	NULL
positive	NULL
or	NULL
negative	NULL
functional	NULL
roles	NULL
in	NULL
the	NULL
HS-40	NULL
enhancer-	NULL
{	NULL
2	NULL
globin	NULL
promoter	NULL
interaction	NULL
is	NULL
unknown	NULL
at	NULL
this	NULL
moment	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
the	NULL
HS-40	NULL
enhancer-mediated	NULL
high	NULL
level	NULL
of	NULL
£2	NULL
globin	NULL
promoter	NULL
activity	NULL
in	NULL
erythroid	NULL
KS562	NULL
cells	NULL
at	NULL
least	NULL
involves	NULL
functional	NULL
,	NULL
and	NULL
probably	NULL
physical	NULL
,	NULL
interaction	NULL
between	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
at	NULL
the	NULL
distal	NULL
and	NULL
proximal	NULL
GATA-1	NULL
motifs	NULL
and	NULL
those	NULL
formed	NULL
in	NULL
the	NULL
HS-40	NULL
regulatory	NULL
region	NULL
.	NULL

Indeed	NULL
,	NULL
functional	NULL
assays	NULL
of	NULL
truncated	NULL
and	NULL
point-muta-genized	NULL
forms	NULL
of	NULL
HS-40	NULL
indicate	NULL
that	NULL
multiple	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
of	NULL
HS-40	NULL
are	NULL
involved	NULL
in	NULL
its	NULL
erythroid-specific	NULL
enhancer	NULL
function	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
expression	NULL
.	NULL

Analysis	NULL
of	NULL
Bal	NULL
31	NULL
deletion	NULL
mutants	NULL
of	NULL
HS-40	NULL
suggests	NULL
that	NULL
GATA-1	NULL
(	NULL
a	NULL
)	NULL
,	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
are	NULL
not	NULL
required	NULL
for	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
in	NULL
transfected	NULL
K562	NULL
cells	NULL
.	NULL

That	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
is	NULL
not	NULL
required	NULL
for	NULL
HS-40	NULL
to	NULL
function	NULL
as	NULL
an	NULL
enhancer	NULL
in	NULL
K562	NULL
cells	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
site-directed	NULL
mutagenesis	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
deletion	NULL
of	NULL
GT-I	NULL
,	NULL
GT-III	NULL
,	NULL
or	NULL
GT-IV	NULL
has	NULL
no	NULL
obvious	NULL
effect	NULL
on	NULL
the	NULL
HS-40	NULL
enhancer	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
5	NULL
``	NULL
NF-E2/AP1	NULL
,	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
,	NULL
and	NULL
possibly	NULL
GT-II	NULL
appear	NULL
to	NULL
form	NULL
the	NULL
functional	NULL
core	NULL
of	NULL
HS-40	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
role	NULL
of	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
was	NULL
not	NULL
immediately	NULL
obvious	NULL
from	NULL
the	NULL
Bal	NULL
31	NULL
deletion	NULL
analysis	NULL
since	NULL
both	NULL
the	NULL
3°	NULL
NF-E2/AP1	NULL
and	NULL
the	NULL
GT	NULL
-II	NULL
motifs	NULL
are	NULL
deleted	NULL
in	NULL
clone	NULL
8	NULL
relative	NULL
to	NULL
clone	NULL
7	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
clearly	NULL
established	NULL
its	NULL
functional	NULL
role	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Whether	NULL
GT	NULL
-II	NULL
is	NULL
a	NULL
functional	NULL
part	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

Although	NULL
clone	NULL
7	NULL
,	NULL
relative	NULL
to	NULL
clone	NULL
6	NULL
,	NULL
has	NULL
2	NULL
bp	NULL
removed	NULL
from	NULL
the	NULL
pentanucleotide	NULL
sequence	NULL
5¢-GGTGG-3	NULL
'	NULL
of	NULL
GT-II	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
the	NULL
main	NULL
body	NULL
of	NULL
the	NULL
genomic	NULL
footprint	NULL
near	NULL
GT	NULL
-II	NULL
in	NULL
K562	NULL
cells	NULL
lies	NULL
to	NULL
its	NULL
left	NULL
part	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
and	NULL
10	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
G-181	NULL
and	NULL
G-182	NULL
may	NULL
not	NULL
be	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
functional	NULL
protein-DNA	NULL
complex	NULL
in	NULL
vivo	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
GT-II	NULL
motif	NULL
.	NULL

Genomic	NULL
footprinting	NULL
data	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
suggest	NULL
that	NULL
the	NULL
function	NULL
of	NULL
the	NULL
core	NULL
HS-40	NULL
elements	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
5°	NULL
NF-E2/API1	NULL
,	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
,	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
and	NULL
the	NULL
GT	NULL
-II	NULL
motif	NULL
,	NULL
is	NULL
most	NULL
likely	NULL
mediated	NULL
through	NULL
the	NULL
cooperative	NULL
interaction	NULL
of	NULL
specific	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
formed	NULL
in	NULL
vivo	NULL
in	NULL
the	NULL
vicin-ities	NULL
of	NULL
these	NULL
motifs	NULL
.	NULL

These	NULL
complexes	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
erythroid	NULL
K562	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
was	NULL
assayed	NULL
,	NULL
but	NULL
not	NULL
in	NULL
nonerythroid	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
except	NULL
for	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
,	NULL
those	NULL
apparently	NULL
nonfunctional	NULL
motifs	NULL
of	NULL
HS-40	NULL
showed	NULL
no	NULL
evidence	NULL
of	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

The	NULL
primary	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
NF-E2/	NULL
AP1	NULL
motifs	NULL
of	NULL
HS-40	NULL
in	NULL
K562	NULL
cells	NULL
is	NULL
most	NULL
likely	NULL
the	NULL
erythroid-specific	NULL
protein	NULL
NF-E2	NULL
,	NULL
although	NULL
the	NULL
participation	NULL
of	NULL
AP1	NULL
could	NULL
not	NULL
be	NULL
completely	NULL
ruled	NULL
out	NULL
.	NULL

An	NULL
in	NULL
vitro	NULL
assay	NULL
has	NULL
shown	NULL
that	NULL
both	NULL
of	NULL
these	NULL
motifs	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
NF-E2	NULL
as	NULL
well	NULL
as	NULL
API	NULL
(	NULL
14	NULL
,	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
point	NULL
mutation	NULL
we	NULL
introduced	NULL
into	NULL
the	NULL
3'°	NULL
NF-E2/AP1	NULL
motif	NULL
would	NULL
abolish	NULL
the	NULL
binding	NULL
of	NULL
NF-E2	NULL
but	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
that	NULL
of	NULL
API	NULL
(	NULL
20	NULL
,	NULL
$	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NF-E2/AP1	NULL
o	NULL
K	NULL
o	NULL
e	NULL
0	NULL
K	NULL
(	NULL
124	NULL
to	NULL
144	NULL
)	NULL
fel	NULL
E	NULL
0	NULL
e	NULL
0	NULL
E	NULL
1	NULL
173	NULL
(	NULL
55173	NULL
)	NULL
nacon	NULL
GTGCTTCTG	NULL
ecacrec	NULL
Tecre	NULL
TTGe	NULL
?	NULL

lacteact	NULL
]	NULL
caccaacgac	NULL
cereace	NULL
ketcaet	NULL
)	NULL
accac	NULL
o	NULL
0	NULL
E	NULL
e	NULL
0	NULL
E	NULL
0	NULL
o	NULL
K	NULL
U	NULL
o	NULL
K	NULL
GT-IUIII	NULL
e	NULL
00°	NULL
OD	NULL
e	NULL
K	NULL
(	NULL
173	NULL
to	NULL
193	NULL
)	NULL
o	NULL
c00	NULL
co	NULL
_	NULL
e	NULL
E	NULL
GTGGG	NULL
A	NULL
GACAA	NULL
cacee|	NULL
ccace	NULL
)	NULL
t|	NULL
coace	NULL
}	NULL
crert	NULL
II	NULL
HI	NULL
GATA-1	NULL
e	NULL
o	NULL
o	NULL
K	NULL
e	NULL
o	NULL
o	NULL
o	NULL
E	NULL
cease	NULL
[	NULL
AGATAA	NULL
]	NULL
crece	NULL
AcTeC	NULL
caace	NULL
corer	NULL
GAGAG	NULL
$	NULL
c'rcc	NULL
Gacec	NULL
$	NULL
GACGGTTGG	NULL
(	NULL
ISGACA	NULL
AATAGAJCTCTC	NULL
(	NULL
106	NULL
)	NULL
b	NULL
(	NULL
212	NULL
)	NULL
¢	NULL
(	NULL
247	NULL
)	NULL
d	NULL
(	NULL
B	NULL
)	NULL
(	NULL
a	NULL
)	NULL
(	NULL
b	NULL
)	NULL
SNEE	NULL
?	NULL

3NFE	NULL
?	NULL

GT	NULL
(	NULL
©	NULL
(	NULL
d	NULL
)	NULL
GATA	NULL
GTI	NULL
GATA-1	NULL
/AP1	NULL
JPL	NULL
TLIN	NULL
IV	NULL
GATA	NULL
GATAI	NULL
in	NULL
vitro	NULL
A1	NULL
__	NULL
q	NULL
C	NULL
T	NULL
~_*~	NULL
0	NULL
Int	NULL
&	NULL
&	NULL
&	NULL
erythroblasts	NULL
a_	NULL
A	NULL
_	NULL
90	NULL
Im	NULL
A	NULL
L	NULL
&	NULL
&	NULL
se	NULL
?	NULL

--	NULL
=	NULL
n	NULL
o	NULL
_m	NULL
ift	NULL
=-	NULL
n	NULL
H	NULL
‘	NULL
Enhancer	NULL
effect	NULL
.	NULL

-	NULL
=	NULL
-	NULL
%	NULL
+	NULL
(	NULL
+	NULL
)	NULL
-	NULL
-	NULL
+	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Summary	NULL
of	NULL
genomic	NULL
footprinting	NULL
data	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

G	NULL
residues	NULL
protected	NULL
from	NULL
or	NULL
hyperreactive	NULL
toward	NULL
the	NULL
DMS	NULL
reaction	NULL
in	NULL
vivo	NULL
in	NULL
K562	NULL
and	NULL
erythroblasts	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
genomic	NULL
footprinting	NULL
analysis	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
and	NULL
9	NULL
,	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
and	NULL
filled	NULL
circles	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Correlation	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
and	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

The	NULL
10	NULL
sequence	NULL
motifs	NULL
of	NULL
HS-40	NULL
with	NULL
the	NULL
potential	NULL
to	NULL
bind	NULL
nuclear	NULL
factors	NULL
are	NULL
indicated	NULL
on	NULL
top	NULL
.	NULL

The	NULL
actual	NULL
patterns	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
in	NULL
vitro	NULL
,	NULL
in	NULL
erythroblasts	NULL
,	NULL
and	NULL
in	NULL
K562	NULL
cells	NULL
are	NULL
exhibited	NULL
on	NULL
the	NULL
first	NULL
,	NULL
second	NULL
,	NULL
and	NULL
third	NULL
lines	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
motifs	NULL
bound	NULL
with	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
boxes	NULL
,	NULL
while	NULL
those	NULL
that	NULL
remain	NULL
unbound	NULL
are	NULL
indicated	NULL
by	NULL
horizontal	NULL
lines	NULL
.	NULL

The	NULL
six	NULL
vertical	NULL
arrows	NULL
indicate	NULL
the	NULL
hyperreactivities	NULL
of	NULL
residues	NULL
G-234	NULL
,	NULL
G-237	NULL
,	NULL
and	NULL
G-238	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
GATA-1	NULL
(	NULL
a	NULL
)	NULL
motif	NULL
in	NULL
erythroblasts	NULL
and	NULL
K562	NULL
cells	NULL
was	NULL
not	NULL
assayed	NULL
and	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
broken	NULL
lines	NULL
.	NULL

The	NULL
asterisks	NULL
(	NULL
*	NULL
)	NULL
indicate	NULL
motifs	NULL
for	NULL
which	NULL
the	NULL
genomic	NULL
footprints	NULL
differ	NULL
between	NULL
erythroblasts	NULL
and	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
apparently	NULL
nonfunctional	NULL
and	NULL
functional	NULL
motifs	NULL
of	NULL
HS-40	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
Bal	NULL
31	NULL
deletion	NULL
mapping	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
a	NULL
site-directed	NULL
mutagenesis	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
are	NULL
individually	NULL
indicated	NULL
by	NULL
-	NULL
and	NULL
+	NULL
signs	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
functionality	NULL
of	NULL
the	NULL
GT-II	NULL
motif	NULL
awaits	NULL
further	NULL
confirmation	NULL
,	NULL
and	NULL
it	NULL
is	NULL
thus	NULL
indicated	NULL
by	NULL
(	NULL
+	NULL
)	NULL
(	NULL
for	NULL
more	NULL
details	NULL
,	NULL
see	NULL
text	NULL
)	NULL
.	NULL

21	NULL
,	NULL
24	NULL
)	NULL
,	NULL
and	NULL
it	NULL
did	NULL
significantly	NULL
decrease	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
binding	NULL
of	NULL
the	NULL
NF-E2	NULL
factor	NULL
to	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
by	NULL
HS-40	NULL
.	NULL

Previous	NULL
protein	NULL
binding	NULL
experiments	NULL
in	NULL
vitro	NULL
showed	NULL
that	NULL
Sp1	NULL
,	NULL
TEF	NULL
2	NULL
,	NULL
and	NULL
another	NULL
unknown	NULL
factor	NULL
might	NULL
bind	NULL
to	NULL
GT-II	NULL
of	NULL
HS-40	NULL
(	NULL
14	NULL
)	NULL
and	NULL
to	NULL
a	NULL
GT	NULL
motif	NULL
in	NULL
the	NULL
5	NULL
'	NULL
HS-2	NULL
enhancer	NULL
of	NULL
the	NULL
B-LCR	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
nature	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
bound	NULL
to	NULL
the	NULL
GT	NULL
motifs	NULL
in	NULL
vivo	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

Interestingly	NULL
,	NULL
there	NULL
exist	NULL
specific	NULL
differences	NULL
in	NULL
the	NULL
genomic	NULL
footprinting	NULL
patterns	NULL
of	NULL
HS-40	NULL
in	NULL
K562	NULL
cells	NULL
in	NULL
comparison	NULL
with	NULL
adult	NULL
erythroblasts	NULL
.	NULL

First	NULL
,	NULL
the	NULL
DMS	NULL
protection	NULL
patterns	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
5°	NULL
NF-E2/AP1	NULL
motif	NULL
differ	NULL
between	NULL
the	NULL
two	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
and	NULL
10A	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
Second	NULL
,	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
GT-II	NULL
motif	NULL
and	NULL
its	NULL
flanking	NULL
DNA	NULL
also	NULL
differs	NULL
in	NULL
that	NULL
the	NULL
extents	NULL
of	NULL
protection	NULL
of	NULL
G-175	NULL
,	NULL
G-176	NULL
,	NULL
G-178	NULL
,	NULL
and	NULL
G-179	NULL
are	NULL
stronger	NULL
in	NULL
K562	NULL
cells	NULL
than	NULL
in	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
and	NULL
10A	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
,	NULL
although	NULL
devoid	NULL
of	NULL
factor	NULL
binding	NULL
in	NULL
vivo	NULL
in	NULL
K56G2	NULL
cells	NULL
,	NULL
appears	NULL
to	NULL
bind	NULL
some	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
adult	NULL
erythroblasts	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
also	NULL
binds	NULL
a	NULL
specific	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
presumably	NULL
GATA-1	NULL
,	NULL
in	NULL
an	NULL
interspecies	NULL
human-mouse	NULL
somatic	NULL
cell	NULL
hybrid	NULL
line	NULL
J3-8B	NULL
which	NULL
is	NULL
of	NULL
adult	NULL
erythroid	NULL
origin	NULL
(	NULL
37	NULL
)	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
these	NULL
differences	NULL
in	NULL
footprints	NULL
may	NULL
reflect	NULL
a	NULL
fundamental	NULL
difference	NULL
in	NULL
the	NULL
structure	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
of	NULL
HS-40	NULL
,	NULL
and	NULL
consequently	NULL
their	NULL
function	NULL
,	NULL
in	NULL
erythroid	NULL
cells	NULL
of	NULL
different	NULL
developmental	NULL
stages	NULL
.	NULL

Strauss	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
have	NULL
used	NULL
a	NULL
guanine	NULL
and	NULL
adenine	NULL
ligation-mediated	NULL
polymerase	NULL
chain	NULL
reaction	NULL
to	NULL
analyze	NULL
the	NULL
genomic	NULL
footprints	NULL
of	NULL
HS-40	NULL
of	NULL
a	NULL
human	NULL
chromosome	NULL
16	NULL
introduced	NULL
into	NULL
mouse	NULL
adult	NULL
erythroid	NULL
environment	NULL
by	NULL
somatic	NULL
cell	NULL
hybridization	NULL
.	NULL

The	NULL
genomic	NULL
footprints	NULL
of	NULL
HS-40	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
J3-8B	NULL
(	NULL
37	NULL
)	NULL
,	NULL
are	NULL
similar	NULL
but	NULL
not	NULL
identical	NULL
to	NULL
those	NULL
in	NULL
the	NULL
human	NULL
adult	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
nuclear	NULL
factors	NULL
appear	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
two	NULL
NF-E2/AP1	NULL
motifs	NULL
and	NULL
three	NULL
GATA-1	NULL
motifs	NULL
[	NULL
(	NULL
b	NULL
)	NULL
,	NULL
(	NULL
c	NULL
)	NULL
,	NULL
and	NULL
(	NULL
d	NULL
)	NULL
]	NULL
in	NULL
both	NULL
J3-8B	NULL
cells	NULL
and	NULL
erythroblasts	NULL
,	NULL
although	NULL
minor	NULL
differences	NULL
in	NULL
the	NULL
DMS	NULL
protection	NULL
patterns	NULL
at	NULL
certain	NULL
G	NULL
residues	NULL
do	NULL
exist	NULL
within	NULL
and/or	NULL
near	NULL
these	NULL
motifs	NULL
.	NULL

Of	NULL
the	NULL
three	NULL
hyperreactive	NULL
G	NULL
residues	NULL
downstream	NULL
from	NULL
the	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motif	NULL
in	NULL
erythroblasts	NULL
and	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
,	NULL
two	NULL
of	NULL
them	NULL
(	NULL
G-237	NULL
and	NULL
G-238	NULL
)	NULL
are	NULL
also	NULL
hyperreactive	NULL
in	NULL
the	NULL
J3-8B	NULL
cells	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
major	NULL
difference	NULL
between	NULL
the	NULL
genomic	NULL
footprints	NULL
of	NULL
J3-8B	NULL
cells	NULL
and	NULL
erythroblasts	NULL
is	NULL
that	NULL
the	NULL
GT-II	NULL
motif	NULL
is	NULL
bound	NULL
with	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
erythroblasts	NULL
but	NULL
not	NULL
in	NULL
J3-8B	NULL
cells	NULL
,	NULL
while	NULL
the	NULL
situation	NULL
with	NULL
the	NULL
GT-IV	NULL
motif	NULL
is	NULL
reversed	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
these	NULL
similarities	NULL
and	NULL
differences	NULL
of	NULL
genomic	NULL
footprints	NULL
at	NULL
the	NULL
HS-40	NULL
region	NULL
in	NULL
J3-8B	NULL
cells	NULL
and	NULL
erythroblasts	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
HS-40	NULL
is	NULL
an	NULL
authentic	NULL
enhancer	NULL
for	NULL
human	NULL
embryonic	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
transcription	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
in	NULL
embryonic	NULL
and/or	NULL
fetal	NULL
erythroid	NULL
cells	NULL
.	NULL

This	NULL
transcriptional	NULL
activation	NULL
process	NULL
appears	NULL
to	NULL
be	NULL
modulated	NULL
by	NULL
interactions	NULL
between	NULL
multiple	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
formed	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
HS-40	NULL
enhancer	NULL
region	NULL
and	NULL
in	NULL
the	NULL
{	NULL
£2	NULL
globin	NULL
promoter	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
a	NULL
modification	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
conformation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
nuclear	NULL
factor-	NULL
DNA	NULL
complexes	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
{	NULL
2	NULL
globin	NULL
gene	NULL
to	NULL
high	NULL
levels	NULL
in	NULL
embryonic	NULL
erythroid	NULL
cells	NULL
and	NULL
the	NULL
a	NULL
globin	NULL
gene	NULL
to	NULL
high	NULL
levels	NULL
in	NULL
adult	NULL
erythroid	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENT	NULL
This	NULL
research	NULL
is	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
DK	NULL
29800	NULL
(	NULL
to	NULL
C.-K.J.S	NULL
.	NULL
)	NULL

and	NULL
DK	NULL
31212	NULL
(	NULL
to	NULL
G.S	NULL
.	NULL

and	NULL
T.P	NULL
.	NULL
)	NULL

.	NULL

C.B	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
predoctoral	NULL
training	NULL
grant	NULL
(	NULL
T32-GM	NULL
07377	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
E.	NULL
A.	NULL
Allegretto	NULL
,	NULL
S.	NULL
T.	NULL
Okino	NULL
,	NULL
K.	NULL
Hattori	NULL
,	NULL
W.	NULL
J.	NULL
Boyle	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1988	NULL
.	NULL

Oncogene	NULL
jun	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
trans-activator	NULL
similar	NULL
to	NULL
AP-1	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
332:166-171	NULL
.	NULL

2	NULL
.	NULL

Antoniou	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1990	NULL
.	NULL

B-Globin	NULL
dominant	NULL
control	NULL
region	NULL
interacts	NULL
differently	NULL
with	NULL
distal	NULL
and	NULL
proximal	NULL
promoter	NULL
elements	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1007-1013	NULL
.	NULL

3	NULL
.	NULL

Boyum	NULL
,	NULL
A	NULL
.	NULL

1968	NULL
.	NULL

Isolation	NULL
of	NULL
mononuclear	NULL
cells	NULL
and	NULL
granulo-cytes	NULL
from	NULL
human	NULL
blood	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

21	NULL
(	NULL
Suppl	NULL
.	NULL

97	NULL
)	NULL
:77-88	NULL
.	NULL

4	NULL
.	NULL

Caterina	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
T.	NULL
M.	NULL
Ryan	NULL
,	NULL
K.	NULL
M.	NULL
Pawlik	NULL
,	NULL
R.	NULL
D.	NULL
Palmiter	NULL
,	NULL
R.	NULL
L.	NULL
ENHANCER-PROMOTER	NULL
INTERACTION	NULL
OF	NULL
HUMAN	NULL
{	NULL
2	NULL
GLOBIN	NULL
GENE	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

2307	NULL
Brinster	NULL
,	NULL
R.	NULL
R.	NULL
Behringer	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Townes	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
:	NULL
analysis	NULL
of	NULL
the	NULL
5°	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
HS2	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:1626-1630.	NULL
.	NULL

Collins	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Weissman	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
molecular	NULL
genetics	NULL
of	NULL
human	NULL
hemoglobin	NULL
.	NULL

Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

31:315-421.	NULL
.	NULL

Das	NULL
Gupta	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
K.	NULL
Samoszuk	NULL
,	NULL
T.	NULL
Papayannopoulou	NULL
,	NULL
and	NULL
G.	NULL
Stamatoyannopoulos	NULL
.	NULL

1985	NULL
.	NULL

SFL	NULL
23.6	NULL
:	NULL
a	NULL
monoclonal	NULL
antibody	NULL
reactive	NULL
with	NULL
CFU-E	NULL
,	NULL
erythroblasts	NULL
,	NULL
and	NULL
erythrocytes	NULL
.	NULL

Blood	NULL
66:522-526.	NULL
.	NULL

Evans	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Felsenfeld	NULL
,	NULL
and	NULL
M.	NULL
Reitman	NULL
.	NULL

1990	NULL
.	NULL

Control	NULL
of	NULL
globin	NULL
gene	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6:95-124.	NULL
.	NULL

Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
S.	NULL
Takegawa	NULL
,	NULL
T.	NULL
Papayannopoulou	NULL
,	NULL
G.	NULL
Stam-	NULL
atoyannopoulos	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
locus	NULL
activating	NULL
region	NULL
:	NULL
the	NULL
formation	NULL
of	NULL
developmentally	NULL
stable	NULL
hypersensitive	NULL
sites	NULL
in	NULL
globin	NULL
expression	NULL
hybrids	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:10159-10177.	NULL
.	NULL

Gong	NULL
,	NULL
Q.	NULL
H.	NULL
,	NULL
J.	NULL
Stern	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Dean	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
role	NULL
of	NULL
a	NULL
conserved	NULL
GATA-1	NULL
site	NULL
in	NULL
the	NULL
human	NULL
s-globin	NULL
gene	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2558-2566	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

Grosveld	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
,	NULL
B.	NULL
v.	NULL
G.	NULL
Assendelft	NULL
,	NULL
D.	NULL
R.	NULL
Greaves	NULL
,	NULL
and	NULL
G.	NULL
Kollias	NULL
.	NULL

1987	NULL
.	NULL

Position-independent	NULL
,	NULL
high-level	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
51:975-985	NULL
.	NULL

Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
W.	NULL
G.	NULL
Wood	NULL
,	NULL
A.	NULL
P.	NULL
Jarman	NULL
,	NULL
J.	NULL
Sharpe	NULL
,	NULL
J.	NULL
Lida	NULL
,	NULL
I.	NULL
M.	NULL
Pretorius	NULL
,	NULL
and	NULL
H.	NULL
Ayyub	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
major	NULL
positive	NULL
regulatory	NULL
region	NULL
located	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-globin	NULL
gene	NULL
locus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1588-1601	NULL
.	NULL

Ikuta	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Y.	NULL
W.	NULL
Kan.	NULL
1991	NULL
.	NULL

/n	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
the	NULL
B-globin	NULL
gene	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:10188-10192	NULL
.	NULL

Jarman	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
W.	NULL
G.	NULL
Wood	NULL
,	NULL
J.	NULL
Sharpe	NULL
,	NULL
G.	NULL
Gourdon	NULL
,	NULL
H.	NULL
Ayyub	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Higgs	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
major	NULL
regulatory	NULL
element	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
gene	NULL
cluster	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:4679-4689	NULL
.	NULL

Karlsson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Nienhuis	NULL
,	NULL
.	NULL

1985	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
human	NULL
globin	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

54	NULL
:	NULL
1071-1108	NULL
.	NULL

Laski	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
B.	NULL
Alzner-Deweerd	NULL
,	NULL
L.	NULL
Rajbhandary	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1982	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
X.	NULL
laevis	NULL
tRNA	NULL
'	NULL
``	NULL
®	NULL
gene	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

10:4609-4626	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49	NULL
;	NULL
741-752	NULL
.	NULL

Liu	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
C.	NULL
Chang	NULL
,	NULL
P.	NULL
Moi	NULL
,	NULL
W.	NULL
Liu	NULL
,	NULL
Y.	NULL
W.	NULL
Kan	NULL
,	NULL
and	NULL
P.	NULL
T.	NULL
Curtin	NULL
.	NULL

1992	NULL
.	NULL

Dissection	NULL
of	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
B-globin	NULL
5	NULL
'	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
2	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:3899-3903	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:499-560	NULL
.	NULL

Mignotte	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
F.	NULL
Eleowet	NULL
,	NULL
N.	NULL
Raich	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Romeo	NULL
.	NULL

1989.	NULL
cis-	NULL
and	NULL
trans-acting	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
erythroid	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6548-6552	NULL
.	NULL

Moi	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Y.	NULL
W.	NULL
Kan.	NULL
1990	NULL
.	NULL

Synergistic	NULL
enhancement	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
by	NULL
activator	NULL
protein-l-like	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9000-9004	NULL
.	NULL

Motamed	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Bastiani	NULL
,	NULL
Q.	NULL
Zhang	NULL
,	NULL
A.	NULL
D.	NULL
Bailey	NULL
,	NULL
and	NULL
C.-K.	NULL
J.	NULL
Shen	NULL
.	NULL

CACC	NULL
box	NULL
and	NULL
enhancer	NULL
response	NULL
of	NULL
human	NULL
embryonic	NULL
e	NULL
globin	NULL
promoter	NULL
.	NULL

Gene	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Wold	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
a	NULL
muscle	NULL
specific	NULL
enhancer	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:780-786	NULL
.	NULL

Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
B.	NULL
P.	NULL
Sorrentino	NULL
,	NULL
K.	NULL
T.	NULL
McDonagh	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Nierhuis	NULL
.	NULL

1990	NULL
.	NULL

Tandem	NULL
AP-1-binding	NULL
sites	NULL
within	NULL
the	NULL
human	NULL
B	NULL
globin	NULL
dominant	NULL
control	NULL
region	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
enhancer	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:993-1006	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
1990	NULL
.	NULL

Globin	NULL
gene	NULL
regulation	NULL
and	NULL
switching	NULL
:	NULL
circa	NULL
1990	NULL
.	NULL

Cell	NULL
63:665-672	NULL
.	NULL

2308	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

ZHANG	NULL
ET	NULL
AL	NULL
.	NULL

Pfeifer	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
D.	NULL
Steigerwald	NULL
,	NULL
P.	NULL
R.	NULL
Mueller	NULL
,	NULL
B.	NULL
Wold	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Riggs	NULL
.	NULL

1989	NULL
.	NULL

Genomic	NULL
sequencing	NULL
and	NULL
methylation	NULL
analysis	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:810-813	NULL
.	NULL

Philipsen	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Talbot	NULL
,	NULL
P.	NULL
Fraser	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
B-globin	NULL
dominant	NULL
control	NULL
region	NULL
:	NULL
hypersensitive	NULL
site	NULL
2	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2159-2167	NULL
.	NULL

Pondel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
M.	NULL
George	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Proudfoot	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
LCR-like	NULL
a-globin	NULL
positive	NULL
regulatory	NULL
element	NULL
functions	NULL
as	NULL
an	NULL
enhancer	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:237-243	NULL
.	NULL

Potter	NULL
,	NULL
H.	NULL
,	NULL
L.	NULL
Weir	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1984	NULL
.	NULL

Enhancer-dependent	NULL
expression	NULL
of	NULL
human	NULL
x	NULL
immunoglobulin	NULL
genes	NULL
introduced	NULL
into	NULL
mouse	NULL
pre-B	NULL
lymphocytes	NULL
by	NULL
electroporation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:7161-7165	NULL
.	NULL

Reddy	NULL
,	NULL
P.	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
C.-K.	NULL
J.	NULL
Shen	NULL
.	NULL

1991	NULL
.	NULL

Protein-DNA	NULL
interactions	NULL
in	NULL
vivo	NULL
of	NULL
an	NULL
erythroid-specific	NULL
,	NULL
human	NULL
B-globin	NULL
locus	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:8676-8680	NULL
.	NULL

Reddy	NULL
,	NULL
P.	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
C.-K.	NULL
J.	NULL
Shen	NULL
.	NULL

1993	NULL
.	NULL

Erythroid	NULL
differentiation	NULL
of	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
results	NULL
in	NULL
reorganization	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
the	NULL
mouse	NULL
B	NULL
'	NULL
``	NULL
globin	NULL
promoter	NULL
but	NULL
not	NULL
its	NULL
distal	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1093-1103	NULL
.	NULL

Romeo	NULL
,	NULL
P.-H.	NULL
,	NULL
M.	NULL
H.	NULL
Prandini	NULL
,	NULL
V.	NULL
Joulin	NULL
,	NULL
V.	NULL
Mignotte	NULL
,	NULL
M.	NULL
Prenant	NULL
,	NULL
Q.	NULL
Vainchenker	NULL
,	NULL
G.	NULL
Marguerie	NULL
,	NULL
and	NULL
G.	NULL
Uzan	NULL
.	NULL

1990	NULL
.	NULL

Megakaryocytic	NULL
and	NULL
erythrocytic	NULL
lineages	NULL
share	NULL
specific	NULL
transcription	NULL
factors	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:447-449	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Selden	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
K.	NULL
Burke-Howie	NULL
,	NULL
M.	NULL
E.	NULL
Rowe	NULL
,	NULL
H.	NULL
M.	NULL
Goodman	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Moore	NULL
.	NULL

1986	NULL
.	NULL

Human	NULL
growth	NULL
hormone	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
regulation	NULL
studies	NULL
employing	NULL
transient	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3173-3179	NULL
.	NULL

Sorrentino	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Ney	NULL
,	NULL
D.	NULL
Bodine	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Nienhuis	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

46	NULL
base	NULL
pair	NULL
enhancer	NULL
sequence	NULL
within	NULL
the	NULL
locus	NULL
activating	NULL
region	NULL
is	NULL
required	NULL
for	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
y-globin	NULL
gene	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:2721-2731	NULL
.	NULL

Stamatoyannopoulos	NULL
,	NULL
G.	NULL
1991	NULL
.	NULL

Human	NULL
hemoglobin	NULL
switching	NULL
.	NULL

Science	NULL
252:383	NULL
.	NULL

Strauss	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
M.	NULL
C.	NULL
Andrews	NULL
,	NULL
D.	NULL
Higgs	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
locus	NULL
upstream	NULL
regulatory	NULL
element	NULL
by	NULL
guanine	NULL
and	NULL
adenine	NULL
ligation	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:2135-2142	NULL
.	NULL

Strauss	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
hypersensitive	NULL
site	NULL
3	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:5809-5813	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
5	NULL
'	NULL
HS2	NULL
of	NULL
the	NULL
globin	NULL
locus	NULL
control	NULL
region	NULL
enhances	NULL
transcription	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
a	NULL
multimeric	NULL
complex	NULL
binding	NULL
at	NULL
two	NULL
functionally	NULL
distinct	NULL
NF-E2	NULL
binding	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1391-1398	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Philipsen	NULL
,	NULL
P.	NULL
Fraser	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1990	NULL
.	NULL

Detailed	NULL
analysis	NULL
of	NULL
the	NULL
site	NULL
2	NULL
region	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
dominant	NULL
control	NULL
region	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2169-2178	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
W.	NULL
B.	NULL
Solomon	NULL
,	NULL
Q.	NULL
L.	NULL
Li	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
London	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
``	NULL
B-like-globin	NULL
'	NULL
``	NULL
'	NULL
gene	NULL
domain	NULL
in	NULL
human	NULL
erythroid	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:6384-6388	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
W.	NULL
B.	NULL
Solomon	NULL
,	NULL
I.	NULL
M.	NULL
London	NULL
,	NULL
and	NULL
D.	NULL
P.	NULL
Lee	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
erythroid-specific	NULL
developmental-stage-independent	NULL
enhancer	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
B-like	NULL
globin	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2554-2558	NULL
.	NULL

Yu	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
J.	NULL
Chen	NULL
,	NULL
L.-I	NULL
.	NULL

Lin	NULL
,	NULL
M.	NULL
Tam	NULL
,	NULL
and	NULL
C.-K.	NULL
J.	NULL
Shen	NULL
.	NULL

1990	NULL
.	NULL

Cell	NULL
type-specific	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
the	NULL
human	NULL
{	NULL
-glo-bin	NULL
upstream	NULL
promoter	NULL
region	NULL
:	NULL
displacement	NULL
of	NULL
Spl	NULL
by	NULL
the	NULL
erythroid	NULL
cell-specific	NULL
factor	NULL
NF-E1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:282-294	NULL
.	NULL

